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SUMMARY 
It is now well established that amenorrheic athletes have low vertebral bone density (Nilson 
and Westlin, 1971; Cann et al., 1984; Drinkwater et al., 1984; Marcus et al., 1985; Drinkwater 
et al., 1986; Nelson et al., 1986; Myburgh et al., 1993). Bone mineral density (BMD) in this 
population may be influenced by a variety of factors including current menstrual status, 
menstrual history, body mass, functional loading and calcium balance. Complex 
interrelationships between these variables may exist. 
The long-term consequences of menstrual irregularities are still unknown, as most studies to 
determine the effect of amenorrhea on BMD in women athletes have been performed on 
young subjects (Drinkwater et al., 1984; Marcus et al., 1985; Drinkwater et al., 1986; 
Drinkwater et al., 1990). Drinkwater et al. (1986) and Lindberg et al. (1987) have also shown 
that the osteopenia induced by amenorrhea is, at least partially, reversible in athletes who have 
regained menses. The question is whether the resumption of normal menses in these women 
is sufficient to counterbalance all of the negative effect of their oligo/amenorrhea. A study by 
Marcus et al. (1985) found that bone mineral density of the lumbar spine in amenorrheic 
runners was lower than that in cyclic women, as well as sedentary, age-matched controls. 
Lack of regular exercise may therefore be less detrimental to lumbar spine BMD than a 
history of menstrual irregularity associated with running. However it is also important to 
consider the age at which this menstrual irregularity occurs as well as the age when bone mass 
is determined. There is still controversy surrounding the time at which peak bone mass is 
achieved (Buchanan et al., 1988; Bonjour et al., 1991; Szejnfeld et al., 1993). Lindsay et al. 
(1993) indicate that bone mass continues to increase up until the fourth decade. However, 
Recker et al. (1992) indicated that gain in bone mass ends earlier in the third decade, whereas 
Bonjour et al. ( 1991) have suggested that most bone is gained by the end of the second 
decade. 
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In study 1, we measured bone mineral density (BMD) in 25 premenopausal ultramarathon (56 
km) runners aged 29 to 39 years and related risk factors for decreased BMD with actual BMD. 
Fifteen runners who had never had oligo/amenorrhea (R) were compared with 10 oligo-
amenorrheic runners (OA): 4 oligomenorrheic, 2 amenorrheic and 4 with prior 
oligo/amenorrhea. Menstrual, dietary and training data were obtained. BMD of the lumbar 
spine (LS) and proximal femur (F) were measured by dual energy x-ray densitometry. Both 
groups had similar body mass (58 ±8 vs. 57 ±8 kg), running and dietary histories. F BMD 
was not different (p=0.07) and correlated only with BMI (p<0.05; r=0.43). LS BMD was 
lower in OA (0.946 ±0.098 g.cm-2) than R (1.088 ±0.069 g.cm-2; p<0.001). Menstrual 
History Index (MHI), (estimated periods.yr-I since age 13), was higher in R (11.6 ±0.6) than 
OA (9.4 ±2.1; p<0.01). LS BMD correlated with MHI (p<0.0005; r=0.67) and years 
oligomenorrheic (p<0.01; r=-0.58) but not years amenorrheic, parity, breastfeeding, diet or 
training. Lumbar spine BMD was significantly higher in R (1.088 ±0.069 g.cm-2; p<0.001) 
than in subjects with a history of oligomenorrhea, but no history of amenorrhea (HO) (0.953 ± 
0.024 g.cm-2; p<0.005), as well as subjects who had a history of either amenorrhea or both 
oligomenorrhea and amenorrhea (HOA) (0.942 ± 0.131 g.cm-2; p<0.005). The two 
subdivisions of the OA group were not significantly different to each other for lumbar spine 
BMD. 
In the addendum to study 1, we completed the same tests on four additional subjects with a 
history of oligo/amenorrhea in order to provide a wider distribution of subjects in the OA 
group and to have a more even number of subjects with regular menses (R = 15) and with 
current or previous menstrual irregularities (OA=14). There was still no difference in age 
(R:35.5 ± 3.2 vs OA: 36.2 ± 5.1 yr), body mass (R:58.3 ± 7.9 vs OA:56.6 ± 6.6 kg) and BMI 
(R:21.4 ± 2.4 vs OA: 21.0 ± 1.97 kg.m-2) between the two groups. The results of the 
addendum to study 1 were able to provide further evidence of the significant relationship 
between overall MHI and LS BMD (p=0.0001; r=0.67). Lumbar spine BMD also correlated 
significantly with total number of years of amenorrhea (p<0.01, r=-0.53), total number of 
years of oligomenorrhea (p=0.01, r=-0.44), and total number of years ofregular menstruation 
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(p<0.01, r=0.53). However in the subsample of women with a history of menstrual 
irregularity, no particular menstrual variable correlated with lumbar spine BMD. LS BMD 
was lower in OA (0.951 ±0.085 g.cm-2) than R (1.088 ±0.069 g.cm-2; p<0.001), however 
there was no difference between the two groups for the left proximal femur (p=0.08). 
However, after division of the OA group into runners who had resumed regular menses (CR, 
n=6) and runners who were currently oligo/amenorrheic (COA, n=8), lumbar spine BMD of 
the regularly menstruating runners (R) was still significantly higher than both the other two 
groups (R: 1.088 ± 0.069 vs CR: 0.985 ± 0.110 g.cm-2 vs COA: 0.926 ± 0.060 g.cm-2 ; 
p=0.0001), and although the two groups were not different to each other. 
In study 2, we repeated the tests on those runners who had previously participated in study 1 
and who were still running, as well as on a control group of sedentary women. Twelve runners 
(R) and 8 sedentary controls (SC) who had always had regular menstrual periods were 
compared to 9 runners who had a history of oligo/amenorrhea (OA): 1 who was currently 
amenorrheic and 1 who was currently oligomenorrheic. Subjects ranged in age from 29-46 
years. The oligo/amenorrheic runners were significantly younger than the sedentary control 
group (OA: 35.9 ± 4.4 vs SC: 41.6 ± 3.1 yr; p=0.01) but did not differ in age from the 
regularly menstruating group (R: 39.0 ± 3.8 yr). The sedentary control group had a higher 
body mass (SC: 63.3 ± 8.6 vs R: 56.3 ± 7.9; or OA: 54.4 ± 3.8 kg; p<0.05), BMI (SC: 23.9 ± 
3.4 vs R: 20.4 ± 1.8; or OA: 20.0 ± 1.5 kg.m-2; p<0.05), endomorphic component (SC: 6.3 ± 
1.3 vs R: 4.0 ± 0.9; or OA: 3.5 ± 1.1; p<0.001) and fat mass (SC: 21.8 ± 4.8 vs R: 15.8 ± 3.2; 
or OA: 13.7 ± 2.7 kg; p<0.001) than the other two groups, as well as a lower measure of 
ectomorphy (SC: 1.7 ± 1.2 vs R: 3.2 ± 0.9; or OA: 3.2 ± 0.9; p<0.01). We therefore covaried 
for age and body mass when determining whether or not there were differences in BMD 
between the groups. LS BMD of OA was significantly lower than the LS BMD of the R and 
SC groups (OA: 0.948 ± 0.070 vs R: 1.043 ± 0.100; or SC: 1.094 ± 0.077 g.cm-2; p<0.05), 
however the three groups did not differ for BMD of the proximal femur (total, neck, 
trochanter, and intertrochanter). There was no difference in the biochemical markers, 
osteocalcin and deoxypyridinoline/creatinine (Dpd/Creat), between the three groups. Lumbar 
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spine BMD correlated significantly with overall MHI (p=0.001, r=0.45), total number of years 
of amenorrhea (p=O.O 1, r=-0.45), and the total number of years of oligomenorrhea (p<0.05, 
r=-0.38). No dietary or training variables correlated with lumbar spine BMD for the whole 
sample of women. No other BMD parameters, including the total proximal femur, neck of the 
femur, greater trochanter, and the intertrochanteric space, correlated with any body 
composition, menstrual, training or dietary variables. Lumbar spine BMD for the sample of 
runners only, correlated significantly with total number of years of amenorrhea (p<0.05; r=-
0.44) and estimated number of periods per year from 21-30 years (p<0.05; r=0.44). Lumbar 
spine BMD, as well as BMD of the proximal femur and the neck of the femur, for the sub-
group of runners with current and/or prior oligo/amenorrhea was not significantly correlated 
with any of the menstrual variables. Change in BMD of the lumbar spine and the proximal 
femur was not physiologically significant or different between the groups. Change in lumbar 
spine BMD since the last study (three years previously), correlated significantly with change 
in mass since the last study (p=0.05; r=0.36), but was not significantly correlated with change 
in MHI, estimated portions of dairy products per week over the past year, current calcium 
intake, or total energy intake. 
In conclusion, in mature women distance runners low LS BMD is related to a history of 
oligo/amenorrhea regardless of resumption of regular menstrual cycles in some subjects. 
Not only amenorrhea, but also prolonged oligomenorrhea may negatively influence peak adult 
bone mass. Lack of regular exercise is less detrimental to lumbar spine BMD than any history 
of menstrual irregularity associated with running. BMD may not increase substantially 
between 35-45 years of age regardless of menstrual status and menstrual history. 
CHAPTER 1 
Exercise and bone mass: a literature review 
A. (i) BONE: HISTOLOGY & PHYSIOLOGY 
There are 3 phases of bone development which all have important functions in 
maintaining the integrity of bone in order to provide a sturdy, but flexible, framework for 
the body. The first is bone growth which determines bone size, secondly modeling 
determines the shape of the bone, and thirdly remodeling which includes the ongoing 
processes of bone formation and resorption. The shape and size of the bone is maintained 
throughout the remodeling process which has two functions. It is required to maintain 
mineral homeostasis,. as well as to prevent the accumulation of micro fractures or fatigue 
damage (Frost, 1983). An annual turnover rate of approximately 15-30% is achieved by 
remodeling which is carried out by basic multicellular units (BMU) (Frost, 1973) . 
The BMU consists of different cell types which each have a specific function but which 
work together to form lamellar bone. There are 4 steps involved in the bone remodeling 
cycle, (i) activation, the conversion of a part of the bone surface from a passive state to 
active remodeling, (ii) resorption, the eroding of the bone surface by osteoclasts over a 1-
3 week period, (iii) reversal, occurs for a period of 1-2 weeks before, (iv) formation, 
which is the function of osteoblasts and is a two step process of bone matrix synthesis 
and subsequent mineralization (Frost, 1973). 
Bone is a specialised connective tissue with important structural and functional 
capabilities (Baron, 1990). There are two types of bone which are composed of the same 
cells and the same matrix elements; however due to certain structural differences, they 
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have different functions. The external part of bones is formed by a thick and dense layer 
of calcified tissue called cortical, or compact, bone which encloses the medullary cavity 
where the bone marrow is found. Toward the epiphysis, the width of the cortical bone 
becomes progressively thinner and the internal space is filled with a network of thin, 
calcified trabeculae, the trabecular, or spongy, bone. The skeletal system consists of 
approximately 20% trabecular bone, which includes bones such as the vertebrae, while 
the appendicular skeleton consists primarily of cortical bone. An important structural 
difference between the two types of bone is that 80-90% of the volume of the cortical 
bone is calcified, while only 15-25% of the trabecular bone is calcified with the 
remaining volume occupied by the marrow. These structural differences have important 
functional repercussions. Cortical bone has a more mechanical and protective function, 
while trabecular bone has a more metabolic function due to the larger bone surface area to 
bone volume ratio. This results in trabecular bone being more sensitive to its 
environment, such as mechanical loading, serum calcium, cellular messengers, and in 
particular the hormonal status, including parathyroid hormone (PTH), Vitamin D and 
estrogen. This may explain the results of a study by Marcus et al. (1985) in which 
trabecular bone density was higher in a group of regularly menstruating athletes 
compared to a group of equivalently trained women with sustained amenorrhea, whereas 
cortical bone mass did not appear to be affected by the loss of menses and the resultant 
reduction in circulating estrogen. At any one time, most of the bone is in a quiescent 
state, with approximately 20% of trabecular bone and 5% of cortical bone in an active 
remodeling state (Frost, 1987). 
Bone balance is the nett result of bone formation and resorption. During childhood, 
adolescence and early adulthood until peak adult bone mass is attained, a positive balance 
is generally maintained. However, a sustained negative balance, which normally occurs 
with aging, when resorption exceeds formation, will result in a progressive loss of bone. 
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Bone balance responds to mechanical and nutritional factors, such as exercise and diet, as 
well as biochemical and neurological factors (Dalsky, 1990). When estrogen is deficient, 
such as after menopause, the rate of bone loss is accelerated over and above that due to 
the normal bone loss which occurs with aging. Regular mechanical loading in the form 
of bending strains, within the elastic limits of deformation, should theoretically ensure 
that an appropriate level of bone mass is maintained by stimulating a higher rate of 
formation relative to resorption as has been shown in animal models (Raab-Cullen et al., 
1994). Bone is a dynamic organ which can also alter its shape and size in order to adjust 
to the demands and level of strain placed on it. However, if environmental conditions are 
not favourable, such as during estrogen deficiency or calcium deficiency, the adaptation 
of the bone to the mechanical strain of weight-bearing may be negated. The most 
striking example of this is adolescent anorexia nervosa (Bachrach et al., 1990). Thus, 
although physical activity may be beneficial, in the presence of menstrual irregularity or 
a severely low energy intake, its benefits may not be sufficient to prevent a negative 
calcium balance and a nett resultant bone loss (Dalsky, 1990). In the same way, during 
prolonged intervals when mechanical strain is removed altogether, such as during bed 
rest, the bone readjusts to the lower level of strain by increasing the remodeling activity 
with an increase in resorption and no simultaneous increase in bone formation (Frost, 
1987). Bone loss continues until a specific lowest possible baseline is reached which is 
genetically determined and which is preserved even under conditions promoting severe 
bone loss (Lanyon, 1987). 
(ii) BONE MARKERS AND BIOCHEMISTRY 
The mechanism of bone loss due to hypoestrogenism is an increased bone resorption rate 
relative to formation rate (Cann et al., 1984; Lutter, 1983). It is generally accepted that 
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hypoestrogenism causes a disturbance of calcium balance which is tightly coupled to 
parathyroid hormone (PTH) secretion (Heaney and Recker, 1982b ). However, it has also 
more recently been shown that bone may have estrogen receptors which may therefore act 
directly on bone balance (Braidman et al., 1995). Hypoestrogenism can be prevented, or 
at least slowed down, by estrogen replacement therapy in postmenopausal women 
(Horsman et al., 1983; Lindsay, 1990). Bone turnover rate can be indirectly determined 
by biochemical markers of bone formation ( eg. serum osteocalcin) and bone resorption 
( eg. urinary excretion of deoxypyridinoline) (Seibel et al., 1993 ), or directly by 
histological examination of iliac crest biopsies which provide information regarding the 
relative amounts of mineralised bone and unmineralised osteoid, active resorption and 
formation surfaces and the quantity of bone relative to the quantity of porous space in the 
specimen (Melsen and Mosekilde, 1981 ). In some countries iliac crest biopsies are used 
to assist in the physician's decision on appropriate treatment, however a comparison 
between the non-invasive and invasive methods of assessing bone formation and 
resorption (Delmas et al., 1991) found a poor comparison between the level of urinary 
collagen cross-links and the histologic parameters of resorption. This discrepancy may 
indicate a limitation of histomorphometric measurements: a small bone biopsy from a 
defined site may not represent other skeletal sites. Alternatively, a relative weakness of 
biochemical markers of bone turnover rate may be that they represent both cortical and 
trabecular bone turnover rather than specifically trabecular bone turnover which is of 
most clinical significance. In young females with menstrual irregularities neither direct, 
or indirect, markers of bone metabolism are routinely measured. It is also unknown how 
bone turnover rates may influence the recovery of bone mass following athletic 
amenorrhea. 
Serum osteocalcin, a biochemical marker of osteoblastic activity, is a small 
noncollagenous protein which is produced during bone formation, and is thus a useful 
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marker of bone formation rate (Gundberg, 1990). Although osteocalcin, also called bone 
gla protein (BGP), is found mainly in the skeleton, a small amount is present in the blood, 
and this may be due to its release from the extracellular matrix of bone or as a result of 
new protein synthesis. Specific disease states that are characterised by high bone 
turnover (eg. hyperparathyroidism), will result in abnormal concentrations of osteocalcin 
in the blood, which result from changes in either the rate of synthesis, or the rate of 
degradation, of the protein in bone tissue. Serum osteocalcin concentrations show large 
diurnal variation, with levels declining in the morning, reaching the lowest point in the 
afternoon, and then rising again to reach a peak at approximately 4.00 am (Gundberg et 
al., 1985). Serum osteocalcin concentrations are higher in infants and children than in 
adults with an increase occurring at puberty that corresponds to the adolescent growth 
spurt (Gundberg, 1990). Serum osteocalcin is significantly increased after menopause in 
women (Johansen et al., 1988) , however there does not appear to be any change with age 
in men (Gundberg, 1990). In premenopausal women if samples are taken at the same 
time of the day, there is no change in the biochemical markers of bone formation during 
the menstrual cycle (Schlemmer et al., 1993). 
In young adults, serum osteocalcin varies between 2 and 12 ng.ml-1 (Gundberg, 1990). 
Within this range, levels of osteocalcin may be influenced by several factors. Research 
by Kelly et al. (1991) on 70 pairs ofpostmenopausal twins found that serum osteocalcin 
levels are genetically influenced which would suggest that there is some genetic 
regulation of bone turnover rate. Surprisingly, a full 80% of the variance in serum 
osteocalcin in their study could be explained by genetic factors. These data have not been 
confirmed in young adults. However, other research has investigated the differences in 
basal and postexercise osteocalcin levels in athletic and non-athletic males, to determine 
the effect of short-term, moderate-intensity exercise on bone metabolism (Nishiyama et 
al., 1988). This study found that serum osteocalcin levels before a bout of exercise were 
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higher in the athletic group than the non-athletic group, and that the response to exercise 
differed between the groups. Osteocalcin levels remained the same immediately post-
exercise in the athletic group and increased 60 minutes later, but in the non-athletic group 
the serum osteocalcin was significantly increased immediately post-exercise and reverted 
to pre-exercise levels 60 minutes later. However, the physiological significance of this 
difference in response to exercise is unknown. 
More recently it has been discovered that pyridinoline and deoxypyridinoline are good 
markers of bone resorption (Delmas, 1993). Pyridinoline (Pyr) and deoxypyridinoline (D-
Pyr) are cross-links which support the collagen chains within the extracellular matrix. 
Although pyridinoline cross-links are present in the matrix of bone and cartilage, they are 
also present in other connective tissue. However deoxypyridinoline cross-links occur in 
substantial amounts only in bone matrix (the ratio of Pyr/D-Pyr being 2:3). Urinary Pyr 
and D-Pyr are released in response to bone degradation by osteoclasts and urinary levels 
are increased by 50-100% during menopause, however they return to premenopausal 
levels within 6 months of hormone replacement therapy (Uebelhart et al., 1991). Total 
urinary Pyr and D-Pyr excretion also undergoes a circadian rhythm, with a gradual 
decline starting at 8:00 am, reaching a minimum at 5:00 pm-8:00 pm, and then slowly 
rising to reach a peak during the early morning (5:00 am-8:00 am). The decrease 
between 8:00 and 11 :00 am is between 25-35% (Schlemmer et al., 1992). The similarity 
in diurnal variations of the pyridinium cross-links as well as osteocalcin, suggests that 
there is a nocturnal increase in both bone resorption and formation rates. No statistically 
significant changes during the menstrual cycle have been observed in the urinary 
biochemical markers of bone resorption (Schlemmer et al., 1993). 
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B. PHYSIOLOGICAL CHANGES IN BMD WITH AGE 
(i) Attainment of peak bone mass 
It is accepted that bone loss in the general population occurs with increasing age. 
However, there is controversy about when peak bone mass is achieved and when bone 
loss begins (Lindsay et al., 1993; Szejnfeld et al., 1993; Buchanan et al., 1988). It is 
important to note that there may also be a plateau in bone mass after peak bone mass is 
achieved and before bone loss begins. Several studies have found that increases in 
skeletal bone mass appear to dramatically slow down at the levels of both lumbar spine 
and the femoral neck at 15-16 yr of age in female adolescents (Bonjour et al., 1991; 
Theintz et al., 1992), and stress the importance of bone acquisition during adolescence 
(Katzman et al., 1991 ). Results from other data that support this hypothesis showed no 
significant age-related changes in bone density between 20 and 40 years of age 
(Armamento-Villareal et al., 1992; Lloyd et al., 1988), and suggest that a peak is reached 
earlier than age 35 as previously believed (Rodin et al., 1990). Nevertheless, longitudinal 
data should provide the best estimates of the age at which peak bone mass is achieved and 
Recker et al. (1992) have shown in 156 young women followed for up to 5 years that it 
occurs between 28 .3 and 29 .5 years of age. The length of time that peak bone mass is 
maintained before bone loss begins is also subject to controversy. Some studies suggest 
that bone loss occurs in premenopausal women prior to the disruptions in ovarian 
function indicating the onset of menopause (Lindsay et al., 1993 ). However, other studies 
show no statistically significant decline in bone density with age during the 
premenopausal period (Szejnfeld et al., 1993). It is however important to bear in mind 
the limitations of bone densitometry in making the conclusion that bone mineral density 
is maintained up until a certain age, when in fact bone loss may occur in trabecular bone, 
but it is not being detected by densitometry which necessarily evaluates both trabecular 
and cortical bone at the same time. A study by Recker et al. (1992b) on a group of 75 
healthy women nearing menopause (all at least 46 years) found no significant changes 
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(> 1 %/year) in lumbar spine BMD, and not much more for the forearm or total skeleton 
(%/year). The conclusion is that bone loss was not detectable in this longitudinal study in 
premenopausal women. 
(ii) Definitions of osteoporosis 
At any age, and at any particular site, a reduction in bone tissue is a result of an 
imbalance between bone formation and bone resorption rates, the two physiological 
processes that are necessary for bone remodelling. Osteoporosis can be defined as a 
condition of general skeletal fragility which increases the risk of non-traumatic fractures 
due to a reduction in bone mass and the disruption of normal skeletal microarchitecture. 
The risk of osteoporosis increases with age, particularly in females after the onset of 
menopause. However, osteopenia does occur in adolescents and may be a result of 
genetic abnormalities, immobilization, endocrine reproductive abnormalities and 
nutrition. The World Health Organisation has determined a bone density criterion for 
osteoporosis: "BMD below 2.5 SD from the average value predicted for a 25 year old 
Caucasian woman" (WHO study group, 1994). 
(iii) Prevalence of osteoporosis 
The prevalence of osteoporosis is very high. It is thought to affect 15-20 million 
individuals aged> 45 years in the United States (Matkovic et al., 1990). It has been 
estimated that by the age of 90 years as many as 3 2% of women and 17% of men will 
have sustained an osteoporotic hip fracture, and between 12 and 20% of this group will 
die of related complications (Marcus, 1989). 
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(iv) Prevention of osteoporosis 
Bone loss occurs with age and places each individual, but particularly women, at an 
increased risk of certain fractures, such as hip, spine and wrist fractures. Bone loss is not 
apparent on routine x-rays until 30-50% of bone mass is lost. One study on 521 female 
volunteers over a 15 year span has shown that a single bone mass measurement can 
predict the probability of hip fracture (Hui et al., 1989). A later study by the same authors 
(Slemenda et al., 1990) went as far as saying that identifying risk factors for osteoporosis 
is of limited value in identifying women with low bone mass around the time of 
menopause and therefore actual measurement of bone mass is necessary. However, bone 
mass measurement is not a diagnostic test for fracture, rather reduced bone mass over a 
period of time should be considered a risk factor for future fractures (Johnston and 
Melton, 1990). 
(v) Cortical vs trabecular bone loss 
Postmenopausal bone loss amounts to approximately 1-2% per year, which appears to 
decrease at about 5-10 years after menopause (Eisman et al., 1991 ). Women with spinal 
osteoporosis lose similar amounts of cortical bone, but more trabecular bone, than women 
without spinal osteoporosis (Riggs et al., 1981). If bone loss occurs prior to menopause, 
it is thought to be primarily trabecular bone which is lost. Results of a cross-sectional 
study by Buchanan et al. ( 1988) found trabecular bone density to be significantly higher 
in the second (178 ± 8 mg/ml) and third (171 ± 6 mg/ml) decade than the fourth (158 ± 4 
mg/ml) and fifth (140 ± 12 mg/ml) decades, while there was no difference in cortical 
bone between the third (0.711 ± 0.021 mg/ml), fourth (0.721 ± 0.012 mg/ml) and fifth 
(0.736 ± 0.012 mg/ml) decades. Similar results by Riggs et al. (1981) comparing 187 
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normal men and women (20-89 years), and 76 women and 9 men with vertebral fractures 
due to osteoporosis, concluded that in women cortical bone loss did not begin until age 
50, and is accelerated from ages 51-66 years. In women cortical bone loss from the 
appendicular skeleton may be more closely related to estrogen deficiency resulting from 
menopause, than is trabecular bone loss from the axial skeleton which begins earlier. The 
primary mechanism for trabecular bone loss is less clear, and may include a decline in 
physical activity. 
The influence of hormonal factors in relation to menopause cannot be ignored, and it is 
thought that menopause may accelerate the process of bone loss due to a deficiency of 
estrogen (Armamento-Villareal et al., 1992) even if bone is already in a negative bone 
balance prior to menopause. Thus, age at menopause is crucial in determining the onset 
ofrapid bone loss (Lindquist et al., 1981 ). Lindquist et al. (1981) compared 5 groups of 
women from 3 age strata,(mean ages: 46, 54 and 62 years), with different menopausal 
status and found that bone mineral content of the third lumbar vertebra was higher in 
premenopausal, or recently postmenopausal, 54 year-old women (3.85 ± 0.62 g.cm-1) 
than in women of the same age who had been postmenopausal for a longer time (3 .46 ± 
0.49 g.cm-1 ). A similar trend was found for women aged 62 years. They thus concluded 
that there is a relationship between early menopause and accelerated trabecular bone loss. 
(vi) Quantity of bone lost 
It has been hypothesised that the cause of bone loss in most cases of postmenopausal 
osteoporosis is an increased bone resorption rate in the presence of a normal rate of 
formation. There are two hypotheses to explain why the incidence of osteoporosis is 
higher in women than in men. Riggs et al. (1981) hypothesise that women lose more 
bone. The cumulative loss of vertebral BMD from early adulthood to late old-age may be 
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as high as 47% in women and 14% in men (Riggs et al., 1981). Lindquist et al. (1981) 
propose that women have a lower bone mineral density than men because the female 
skeleton contains less bone than the male skeleton at skeletal maturity and therefore 
women start to lose bone from a lower initial bone density. This, along with the 
hormonal influence of menopause, will explain a lower BMD that occurs in older women. 
On the basis of data from Seeman et al. ( 1989) on a group of premenopausal daughters of 
women with and without postmenopausal osteoporosis, a similar conclusion can be made. 
This study concluded that the low bone mass found in patients with osteoporosis is not 
entirely due to excessive bone loss but rather to the attainment of a low peak bone mass. 
This is why it is important to ensure that the peak adult bone density attained is high, as a 
low vertebral BMD in young adulthood is an independent risk factor for a low vertebral 
BMD in later life. The identification of factors that influence the development of peak 
bone mass are vital in order to develop the most appropriate methods for maximising 
bone mass in the developmental period (Armamento-Villareal et al., 1992). 
C. FACTORS THAT DETERMINE PEAK BONE FORMATION 
From the previous discussion we conclude that peak bone mass, along with the age at 
onset of bone loss and the rate of bone loss contribute to the development of osteoporosis. 
A study by Riggs et al. ( 1981) supports the hypothesis that age related bone loss is fairly 
constant in most women and that a relatively low vertebral BMD in young adulthood is 
an independent risk factor for a relatively low vertebral BMD in later life. Therefore low 
peak bone mass is a major cause of osteoporotic fractures and consequently potential 
immense medical expense. 
A combination of a low peak adult bone mass and an increased rate of bone loss at an 
early age could have disastrous effects, as the bone density at the fracture threshold will 
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be reached early and spontaneous fractures are likely to occur. To prevent the onset of 
osteoporosis and the resultant osteoporotic fractures, a high peak bone mass and the 
maintenance of this bone mass must be achieved. Much research has focused on the 
maintenance of bone mass after menopause, whereas less attention has been paid to 
gaining bone mass in the premenopausal period. It is now clear however that peak bone 
mass attained is very important and can be influenced by various factors. Some research 
has suggested that the average premenopausal female may be able to increase BMD in 
her lumbar spine by as much as 10-15% during the years preceding menopause (Kanders 
et al., 1988). This was achieved by a consistent increase in calcium intake of 200-400 
mg/d (previous average calcium intake was about 600 mg/d) together with an increase in 
physical activity resulting in an increase in average energy expenditure of 400 kcal.day- 1. 
A study by Riggs et al. (1981) support the hypothesis that age related bone loss is 
constant in all women and that a relatively low vertebral BMD in young adulthood is an 
independent risk factor for a relatively low vertebral BMD in later life. 
There are a variety of factors that influence the quantity of peak bone mass attained, the 
age at which bone loss begins, and the rate of bone loss. Some of these factors can be 
controlled by lifestyle, however factors such as age, gender and genetics are out of the 
individual's control. A large genetic component may determine the maximum bone mass 
achievable, however several nutritional and lifestyle factors will determine whether an 
individual is able to achieve this level or not. These factors include, amongst others, 
current menstrual status and menstrual history, habitual levels and type of physical 
activity, dietary calcium and Vitamin D intake, lactation and parity, and oral 
contraceptive use. Thus, it has been identified that detailed longitudinal studies of 
menstrual and other factors controlling bone mass in premenopausal women are required 
(Lindsay et al., 1993). 
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C.i Genetic factors 
Genetic factors play a large role in determining achievable peak bone mass and the onset 
and rate of bone loss. Some data suggest that genetic potential has a relatively larger 
influence than environmental factors in the development of premenopausal bone mass. 
One study found that premenopausal women with a low bone mass had a positive 
maternal family history of osteoporosis, while neither dietary habits nor any other 
environmental factors were statistically significantly influencing bone mass (Armamento-
Villareal et al., 1992). The researchers did however accept the limitations of a cross-
sectional study in making these conclusions. Other data support the hypothesis that peak 
bone size, bone mass, and bone density in young women are strongly influenced by 
genetic information not only from the mothers but from fathers as well (Matkovic et al., 
1990), and support the hypothesis that heredity may also be one of the main determinants 
of osteoporosis in elderly people. This study found a resemblance between the mean 
bone status of the parents and that of their daughters for bone size, bone mass, and bone 
density of the appendicular and axial skeleton. At the beginning (age: 14 years) and on 
conclusion (age: 16 years) of the trial, the bone variables of the daughters were expressed 
as percentages of the same variables of their mothers and it was concluded that by the age 
of 16 years, daughters had accumulated 90-97% of the bone mass of their premenopausal 
mothers. Another study reported a significantly lower lumbar spine BMD in the 
premenopausal daughters of osteoporotic mothers compared to other women of the same 
age (Seeman et al., 1989). 
Twin studies may however be more effective in determining the influence of genetic 
factors since in family resemblance studies similarities may be attributed to physical 
activity and nutrition. A study by Pocock et al. (1987) in which they measured lumbar 
spine and proximal femur BMD and forearm bone mineral content in 3 8 monozygotic 
and 27 dizygotic twins, found spine BMD to be more significantly correlated in the 
monozygotic twins than in dizygotic twins. A similar, but less significant, relationship 
was found in the proximal femur and in the forearm of premenopausal twins, suggesting 
that the bone mass of these two sites may be determined more by environmental factors 
than the lumbar spine. 
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Another genetic factor influencing bone mass appears to be a polymorphism in the 
vitamin D receptor. Ferrari et al. (1995) found that the rate of change in lumbar spine 
BMD was greater in 78% of subjects with homozygous alleles (BB), but in only 41 % and 
31 % of subjects with the Bb and bb alleles respectively. The authors concluded that 
variability in BMD response to calcium intake is partly due to genetic factors. 
Thus, as has previously been suggested (Eisman et al., 1991 ), it may be the interaction 
between environmental and lifestyle factors which allows full expression of bone mineral 
density. 
C.ii Training/physical activity 
It is unknown whether bone loss in athletic women follows a different trend relative to 
the general population. Studies with relatively small numbers of subjects, suggest that 
physical activity may prevent age-related premenopausal bone loss (Brewer et al., 1983; 
Davee et al., 1990). Indeed "age-related premenopausal" may be a misnomer and 
premenopausal bone loss may be simply due to age-related decline in physical activity. 
Brewer et al. (1983) concluded from their study comparing marathon runners to sedentary 
controls that bone mineralisation may be enhanced in premenopausal middle-aged (30-49 
years of age) women who participate in moderate to intense exercise, with an inferred 
consequence being a lower risk of fracture later in life. Several studies have found that 
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athletes involved in weight-bearing activities, such as running, volleyball, basketball and 
gymnastics, have higher bone densities than non-athletes (Brewer et al., 1983; Marcus et 
al., 1985, Risser et al., 1990, Taaffe et al., 1995). A study by Bassey and Ramsdale, 
(1994), divided a group of healthy premenopausal women (n=27) into a test group who 
performed high-impact exercise and a control group who were on a programme of low-
impact exercise. Results after 6 months on the programmes showed a significant increase 
in trochanteric bone density in the test group, and this was significantly different to the 
control group. For the next 6 months the two groups were crossed over, and the previous 
control group showed a significant increase in trochanteric density with high impact 
exercise, while the previous test group maintained their improvement relative to baseline. 
However, athletes who participate in activities that do not involve vertical weight-bearing 
activity, such as swimming, may not be protected from low bone mineral density of the 
lumbar spine (Risser et al., 1990; Taaffe et al., 1995). A contentious issue is still whether 
women with relatively higher BMD choose to participate in regular physical activity or 
whether their higher BMD is a result of their exercise habits. Although Smith and 
Gilligan ( 1987) have concluded from their review that weight-bearing activities such as 
walking, running, and racket sports seem to be more effective in maintaining integrity of 
the neck of the femur and the spine than nonweight-bearing activities such as bicycling 
and swimming, only longitudinal studies using exercise as intervention will be able to 
definitely solve this issue. Even then, variables such as previous habitual exercise 
patterns and starting level of BMD may affect the outcome of intervention studies. 
The effect of physical activity on bone mass is not only relevant to the athletic 
population. Rather the effects of the normal range of activity most likely to be 
undertaken in daily living and leisure time is possibly even more important, since the 
athletic population is relatively small. A study by Kanders et al. (1988) on a sample of 
non-athletic women with a stable life-style showed a highly significant correlation 
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between BMD in the lumbar spine and overall level of physical activity. This 
relationship suggested that a slight increase in daily activity such as a 4 mile walk, could 
result in an increase of as much as 5% in vertebral BMD by the time of onset of 
menopausal bone loss. However, a limitation of the Kanders et al., (1988) study was that 
total energy expenditure was estimated without taking into account the effect of body 
weight, and when energy expenditure (kcal.daf1) is divided by body weight there is no 
longer a significant regression between average energy expenditure and vertebral bone 
mineral density. A similar study by Halioua and Anderson ( 1989) investigated lifetime 
physical activity habits of a group of healthy premenopausal women (20-50 year; n= 181) 
and found significant relationships between lifetime physical activity habits and BMD 
and BMC of the distal radius and the mid-radius. They concluded that good exercise 
habits during the formative years of adolescence and early adulthood should maximise 
the genetic potential for bone mass of the individual. 
Although these cross-sectional studies can lay scientifically sound foundations for 
hypotheses, controlled intervention studies are required to substantiate them. However, 
most intervention studies to date have been done on postmenopausal women. For 
example Dalsky et al. (1988) found that in a group of healthy, sedentary, postmenopausal 
women who completed a 9-month program of weight-bearing exercise, BMC of the 
lumbar spine increased significantly. The increase in lumbar spine BMC was maintained 
with a long term program. However, after a 13 month period of detraining, mean BMC 
for the group had returned to just above baseline. Although these data were collected in 
postmenopausal women, they suggest that the skeleton is indeed responsive to physical 
activity, but that the level of activity should be maintained or the benefit will be lost. 
Snow-Harter et al. (1992) conducted an 8-month intervention trial on a group of 31 
healthy, premenopausal women (mean age 20 years) who were randomly assigned to a 
control group, or to progressive training in jogging or weight-training. The study found a 
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significant increase in lumbar spine BMD in the runners and weight-trainers, in 
comparison to the control subjects in whom BMD did not change. There was no 
significant difference in lumbar spine BMD between the 2 exercising groups. Similar 
results were obtained in a 2-year intervention trial by Friedlander et al. (1995). One 
hundred and twenty seven women (ages of 20-35 years) were randomly assigned to either 
an exercise program that contained both aerobics and weight training, or to a stretching 
program. The results of this study showed a significant difference in BMD between the 
two groups, as well as a significant gain in BMD between the two groups. Results of a 
prospective study by Rockwell et al. (1990) concluded however that short term weight 
training may result in a decrease of vertebral bone mass in premenopausal women. This 
study compared the lumbar spine bone mass of 10 women (36.2 ± 1.3 years of age) on a 
weight training program with 7 sedentary women (40.4 ± 1.6 years of age). Although 
there was an increase in muscle strength at the end of the 9 month program, the lumbar 
spine bone density in the exercising women was significantly decreased. 
If weight-bearing activity is such an important determinant of BMD it seems logical that 
body weight may also play a role in the attainment of peak bone mass, either as a function 
of a larger skeleton (bone mass) or in conjunction with weight-bearing exercise (bone 
density). Different studies have noted a positive relationship between several parameters 
of body stature and bone mineralisation (Brewer et al., 1983; Mazess and Barden, 1991; 
Warren et al., 1991; Jonnavithula et al., 1993; Young et al., 1994;), indicating that larger 
women do indeed have greater bone mass, and in particular a higher bone mineral 
density. Conversely, women with smaller stature have lower bone mass A study by 
Drinkwater et al. (1990) in athletic premenopausal women aged 18-3 8 years, found body 
weight to be a significant predictive variable for bone density at all of seven sites 
measured, including lumbar spine, femoral neck and shaft, tibia, fibula, and the distal 
radius and shaft of the radius. The authors suggested two other possible explanations for 
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this relationship. Firstly, the skeleton will respond to the stress placed on it by the 
additional body mass, and secondly, there is increased conversion of androgens to estrone 
in the adipose tissue of the heavier women. But body weight predicted BMD of weight-
bearing as well as non weight-bearing sites in this study, indicating that the relationship is 
more complex than a simple gravitational response. A strong positive correlation 
between body weight and BMC has also been shown in a group of perimenopausal 
women (Lindquist et al., 1981 ). However, these authors suggested another potential 
variable which may explain this association: they hypothesised that there may be a later 
onset of menopause in women with a higher % body fat. It is therefore clear that the 
effect of body weight on BMD is multifactorial. 
C.iii Muscle mass/strength 
Similar to the positive relationship between body mass and bone mass, a positive 
correlation has been demonstrated between muscle mass and bone mass (Aloia et al., 
1995). This may be due to the relationship between body mass and muscle mass and 
therefore merely another method of relating body size to bone mass. However, cross-
sectional studies showing higher BMD in weight lifters than other athletes suggest that 
weight training may provide a better stimulus for improving bone status than running and 
swimming (Nilson and Westlin, 1971; Heinrich et al., 1990; Davee et al., 1990). In a 
group ofregularly menstruating female resistance and endurance trained athletes, fat-free 
body weight was the best predictor of bone mineral content (Heinrich et al., 1990). 
Therefore, the relationship between muscle mass and bone mass may be due to skeletal 
loading during weight training or other activities that cause muscle hypertrophy. Indeed, 
bone remodeling has been shown to occur in response to site-specific mechanical loading 
(Davee et al., 1990; Madsen et al., 1993). For example, Davee et al. (1990), showed that 
lumbar BMD was greatest in women who supplemented their aerobic exercise with 
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muscle-building activities, including arm, leg, chest and back exercises. They concluded 
that as the lumbar spine is the site of maximal resistance loading by arm and leg lifts, as 
well as back strengthening exercises, bone remodelling occurs mainly at sites where 
mechanical loading is maximal. However, Snow-Harter et al. (1990) concluded that 
although muscle strength is the most significant independent predictor of BMD and may 
account for 15-20% of the total variance in bone density in young women, it is more 
complex than a simple site-specific relationship between the muscle attachments and the 
bone. In that study biceps strength was an independent predictor of BMD at the hip, and 
grip strength best predicted lumbar spine density. It is not clear whether this finding is 
best explained by the systemic hormonal effect of exercise, or whether the biceps curl is 
an exercise which is most representative of overall exercise habits influencing the whole 
body. 
C.iv Menstrual and medical factors 
a. Menstrual status: current and history 
The rapid loss of BMD following menopause illustrates the fact that normal reproductive 
hormonal status is one of the most important requirements for maintenance of bone 
mineral density, and consequently is highly likely to influence the attainment of peak 
adult bone mass. Research in premenopausal women has found that estrogen status 
( determined by a combination of age at menarche, average length of menstrual cycles 
since menarche, and circulating estrogen levels) is the most important determinant of 
bone mass in Caucasian women (Lloyd et al., 1988; Armamento-Villareal et al., 1992). 
Values within the normal range for these factors, along with age, previous pregnancy and 
use of birth control pills, are determinants of reproductive maturity and have been shown 
to be protective against development of menstrual dysfunction in premenopausal women 
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(Loucks and Horvath, 1985). Female athletes are a population at risk of developing 
menstrual dysfunction (Speroff and Redwine, 1980; Schwartz et al., 1981 ), particularly 
those participating in sports that place emphasis on leanness (Rippon et al., 1988). Since 
one of the important potential benefits of regular physical exercise is increased bone 
mineral density, (Lane et al., 1990; Risser et al., 1990) it is incongruous that the 
beneficial effects of exercise are negated or reversed in those athletes who experience 
menstrual cycle disruption and certain hormonal deficiencies (Drinkwater et al., 1984; 
Lindberg et al., 1984; Drinkwater et al., 1986). Many studies have identified a 
significant, direct relationship between current menstrual status and bone mineral density 
in both sedentary and exercising subjects (Cann et al., 1984; Drinkwater et al., 1984; 
Lindberg et al., 1984; Marcus et al., 1985; Nelson et al., 1986; Cook et al., 1987; 
Drinkwater et al., 1990; Warren et al., 1991; Jonnavithula et al., 1993; Myburgh et al., 
1993; Rutherford, 1993; Micklesfield et al., 1995)(See Table 1.1). These studies 
unanimously indicate that amenorrhea is associated with lower lumbar spine BMD than 
in both control athletes (Drinkwater et al., 1984; Lindberg et al., 1984; Marcus et al., 
1985; Nelson et al., 1986; Drinkwater et al., 1990; Warren et al., 1991; Jonnavithula et 
al., 1993; Myburgh et al., 1993; Rutherford, 1993) and sedentary controls (Cann et al., 
1984; Lindberg et al., 1984; Marcus et al., 1985; Jonnavithula et al., 1993; Rutherford, 
1993). 
It is important to note that not only amenorrhea is associated with low BMD. Many 
female runners who may be classified as eumenorrheic, due to a regular number of cycles 
per year, may be experiencing short luteal phases, anovulation or both (Shangold et al., 
1979). A study by Prior et al. (1990) on 66 premenopausal (21-42 years) women of 
varying activity levels, found that the inadequate production of progesterone, which 
occurs in cycles of short luteal phases and anovulatory cycles, was associated with 
accelerated bone loss, despite normal production of estradiol and the presence of regular 
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menses. Also Lloyd et al. (1988) showed that even moderate oligomenorrhea ( 6-7 
menses/year) is sufficient to cause reduced lumbar spine BMD. This has also been 
shown by Cook et al. (1987) and Drinkwater et al. (1990). The significance of this bone 
loss has been highlighted in a study by Myburgh et al. (1990) which showed that athletes 
with stress fractures had significantly lower lumbar spine BMD, a higher incidence of 
current menstrual irregularity and a lower incidence of oral contraceptive use than the 
age- and exercise-matched control athletes who had never had a bone injury. 
Some cross-sectional studies have also looked in more detail at the overall history of 
menstrual dysfunction instead of focusing only on the current status (Drinkwater et al., 
1990; Grimston et al., 1990a; Myburgh et al., 1993; Micklesfield et al., 1995). 
Drinkwater et al. (1990) found a significant relationship between a score ( category 1-9) 
derived from combining current and previous menstrual status and current lumbar spine 
BMD. Those subjects who scored 1 (always regular) tended to have the highest BMD 
and those subjects scoring 8 ( current amenorrhea with a history of oligomenorrhea) and 9 
(primary amenorrhea) tended to have the lowest BMD. Interestingly, a study by 
My burgh et al. (1993) which calculated the number of years of amenorrhea, the number 
of years of regular menstruation and the estimated total number of periods missed found 
that the most robust predictor of lumbar spine BMD was the number of years of regular 
menstruation. In that study no significant relationship between lumbar spine BMD and 
years of amenorrhea, or total periods missed since menarche, was found. Their 
explanation for this was that the BMD deficit noted in amenorrheic women may not 
necessarily only reflect bone loss, but may also be due to inadequate bone gain during 
adolescence and early adulthood. Other methods of quantifying menstrual history have 
estimated the overall average number of periods per year, so that years of regular menses 
are taken into account (Grimston et al., 1990a; Micklesfield et al., 1995). The calculated 
menstrual history indexes support the findings of both Drinkwater et al. ( 1990) and 
Myburgh et al. (1993). 
It is clear that women athletes with menstrual irregularities are at risk of not achieving 
their peak adult bone mass due to a combination of factors relating to their current and 
previous menstrual status, such as age at menarche, average length of menstrual cycles, 
use of birth control pills and previous pregnancy. 
b. Trabecular bone vs cortical bone 
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Several studies have found a significant difference in trabecular bone density between 
regularly menstruating athletes and athletes with secondary amenorrhea, with no 
difference in cortical bone mass between the two groups (Cann et al., 1984; Drinkwater et 
al., 1984; Marcus et al., 1985; Nelson et al., 1986; Rutherford, 1993)(See Table 1.1). It is 
likely that bone mineral deficits are greater in trabecular bone than in compact bone due 
to the greater surface-to-volume ratio in trabecular bone. The bone surface is exposed to 
the hormonal milieu and similar to the hypoestrogenic state associated with menopause, 
lower circulating estradiol levels have been found in amenorrheic young women 
compared to women with regular menstrual periods (Cann et al., 1984; Drinkwater et al., 
1984; Nelson et al., 1986). A positive linear correlation between lumbar spine BMD and 
serum estradiol (Nelson et al., 1986) supports this hypothesis. A study by Young et al. 
(1994) concluded that cortical bone in weight-bearing regions of the body will benefit 
more from weight-bearing exercise and suffer less from hypoestrogenism. Young et al. 
(1994) postulate that cortical bone may be more responsive to mechanical loading as it is 
normally adjacent to, or receives, direct muscle insertions while trabecular bone is more 
central and encased by cortical bone. Cortical bone may be less sensitive to estrogen 
deficiency than trabecular bone because it has a lower inherent turnover rate. Conflicting 
results from a study by Myburgh et al. (1993) found that cortical bone is not necessarily 
protected from mineral loss as BMD of the femoral mid-shaft and neck (where the 
proportion of cortical bone may be as high as 50%) was significantly lower in the 
amenorrheic group than the regularly menstruating group, despite similar body weight. 
Trabecular bone is more sensitive to hypoestrogenism, while cortical bone may be more 
responsive to mechanical loading rather than estrogen deficiency. 
c. Age at menarche 
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Delayed menarche and intensive training at a young age may also contribute to 
subsequent development of amenorrhea and a higher incidence of bone injuries, as some 
studies have shown a later age at menarche in amenorrheic runners (Nelson et al., 1986; 
Drinkwater et al., 1990; Rutherford, 1993; Warren et al., 1991; Sanborn et al., 1987; 
Myburgh et al., 1993). Marcus et al. (1985) showed that the amenorrheic athletes in their 
study had commenced training within 1 year of menarche, whereas athletes with regular 
menstrual cycles did not begin training for competition until approximately 5 years later. 
These findings may be explained by the hypothesis that intensive endurance training 
affects the immature hypothalamic-pituitary-gonadal function more than it would once 
regular menstrual cycles have been established (Marcus et al., 1985). Delayed menarche 
in a normal, non-athletic population of women may also result in reduced BMD. In a 
study by Armamento-Villareal et al. (1992) an inverse relationship between vertebral 
bone density and age at menarche was found. This study showed that reaching sexual 
maturity earlier in life will increase the exposure of the skeletal tissue to the beneficial 
effects of estrogen. Similarly Bachrach et al. (1990) have shown that BMD is highly 
significantly lower in amenorrheic anorexic teenagers than in age-matched controls. 
Therefore both adequate nutritional status and adequate estrogen is important for bone 
mineralisation during the rapid growth phase. 
d. Resumption of menses 
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It is apparent that young women with a history of irregularity generally have lower BMD 
than age-matched controls. The question is whether the resumption of normal menses in 
these women is sufficient to counterbalance the negative effect of transient 
hypoestrogenism within the fertile period (Drinkwater et al., 1990; Armamento-Villareal 
et al., 1992). Drinkwater et al. (1986) have shown that after resumption of regular 
menses, previously amenorrheic athletes show a significant increase in lumbar spine 
BMD over a 15 month period, with no change in the cyclically menstruating women over 
this period. However, the level of lumbar spine BMD attained by the previously 
amenorrheic athletes was still significantly lower than control athletes. The resumption 
of menses in this group of previously amenorrheic runners coincided with a decrease in 
mileage due to injury or illness, and the substitution of running with other activities. 
There was also a significant increase in body weight during the 15 month period and five 
of the previous nine amenorrheic athletes reported an increase in consumption of dairy 
products and/or calcium supplementation over the previous year. Similarly, research by 
Lindberg et al. (1987), also over a 15 month period in which previously amenorrheic 
athletes took supplemental calcium and reduced their running distance, showed that along 
with an increase in body weight, increased estradiol levels and eumenorrhea, there was a 
6,6% increase in lumbar spine bone mineral density. Our study (Micklesfield et al., 
1995) in somewhat older women showed that any history of menstrual irregularity was 
more predictive of BMD than was current menstrual status, indicating that BMD may 
never be regained in sufficient quantity to match women who have always been 
eumenorrheic. If these data are repeatable, it is unknown why BMD does not recover to 
normal premenopausal levels. 
e. Oral contraceptive use, lactation history and parity 
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Other factors related to reproductive history such as use of oral contraceptives and parity 
may have a positive influence on peak adult bone mass, although a long history of 
lactation may be a negative influence. Several studies have found no relationship 
between the use of oral contraceptives and BMD (Hreshchyshyn et al., 1988; Lloyd et al., 
1989; Mazess and Barden, 1991 ). Oral contraceptive use in women athletes has been 
shown to protect against the development of stress fractures and other musculoskeletal 
injuries (Lloyd et al., 1985; Myburgh et al., 1990), as well as early age-related bone loss 
(Recker et al., 1992a) and may therefore have an effect on achieving peak bone mass. It 
is still uncertain however whether oral contraceptives used specifically to correct 
menstrual irregularities will improve bone mass or merely prevent bone loss. 
In a study by Lindquist et al. (1981) on women from three different age strata ( 46, 54 and 
62 years), there was no relationship between parity and bone mineral content. Sowers et 
al. (1993) found that women who breastfeed for more than 6 months have reduced BMD 
of the lumbar spine and the femoral neck. This is in contrast to research by Koetting and 
Wardlaw (1988) who found no association between a history of long-term lactation and 
low bone density in the lumbar vertebrae and the femoral neck. However, this 
discrepancy in results may be explained by the fact that BMD of the lumbar spine has 
been shown to return to baseline levels within 12 months of stopping breastfeeding 
(Sowers et al., 1993). The return of BMD to baseline levels may also be influenced by 
dietary calcium intakes. Athletic women tend to have paradoxically low energy intakes 
and some studies have also documented low intakes of calcium (Nelson et al., 1986; 
Myburgh et al., 1988; Myburgh et al., 1990). There is as yet little information regarding 
the combination of breastfeeding and dietary habits of mature athletic women. 
f. Training and menstrual function 
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A relationship has also been found between distance run, ie. mileage per week, and 
chronic menstrual dysfunction (Schwartz et al., 1981; Lindberg et al., 1984; Drinkwater 
et al., 1984; Drinkwater et al., 1986; Cook et al., 1987; Drinkwater et al., 1990). A study 
by van Gend and Noak es ( 1987) found that all of the amenorrheic and 3 of the 
oligomenorrheic women in their study were running over 75 km/wk, while no one who 
ran under 35 km/wk experienced any changes in their menstrual pattern. Other studies 
have not found a relationship between menstrual irregularity or amenorrhea and weekly 
mileage (Speroff and Redwine, 1980; Nelson et al., 1986; My burgh et al.; 1993). 
However, a study by Schwartz et al. (1981) found that the group of amenorrheic runners 
had been running for a longer period of time than those runners with regular cycles. 
Running mileage should however not be considered in isolation, as chronic menstrual 
dysfunction may be the result of a combination of lifestyle factors associated with 
running, such as sustained heavy training, frequent intensive competition and chronic low 
body weight due to a kilojoule-restricted diet. Indeed, My burgh et al. ( 1992) have shown 
that an athlete's risk of menstrual dysfunction increases with the presence of more risk 
factors and that no single risk factor is more important than another. Therefore, those 
factors which promote menstrual dysfunction may also indirectly promote bone loss and 
prevent the achievement of the genetically predetermined potential peak adult bone mass 
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C.v Nutrient intake 
a. Kilojoule intake 
As stated above, women athletes report a reduced kilojoule intake relative to their high 
energy expenditure (Marcus et al., 1985; Nelson et al., 1986; Van Gend and Noakes, 
1987). Our previous research has found a significant relationship between total energy 
intake and the Menstrual History Index, a measure of menstrual irregularity, and therefore 
suggests that there is a relationship between current energy intake and the history of 
menstrual dysfunction which may be related to a history of chronic undernutrition 
(Micklesfield et al., 1995). Results of a study by Drinkwater et al. (1984) showed a daily 
energy intake of 6817 kJ in a group of amenorrheic athletes compared to 8253 kJ in their 
control group of eumenorrheic athletes, a difference (p<0.06) which closely approached 
the level of significance (p=0.05) established for the study. Marcus et al. (1985) also 
reported a difference in energy intake between their group of amenorrheic runners (5342 
kJ) and their age-matched controls (7203 kJ), however the large variance in the data 
prevented these values from reaching statistical significance. Thus, previous and current 
energy intake, specifically in women athletes, may also indirectly influence peak bone 
mass. 
b. Calcium intake 
Adequate calcium intake during the adult years is necessary to maintain calcium balance 
and a strong skeleton and therefore calcium deficiency contributes to bone loss (Heaney 
et al., 1982a). Not only current calcium intake but also the history of calcium intake, ie. 
during adolescence and in the early 20s, is important in the attainment of peak adult bone 
mass (Halioua and Anderson, 1989). Calcium intake is an important determinant of peak 
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bone mass among young adults and it has been hypothesized that calcium influences 
skeletal calcium retention during bone growth (Matkovic et al., 1990). Calcium intake 
may also be particularly important in exercising adults since Myburgh et al. (1990) have 
shown that athletic subjects (men and women) with stress fractures had a significantly 
lower current intake of dietary calcium and also a lower estimated intake of dairy 
products since leaving school, than did control athletes who had never had a bone injury. 
Even shin soreness without frank tibial stress fractures have been associated with low 
dietary intakes of calcium (Myburgh et al., 1988). However it would appear that the 
relationship is not simple. A cross-sectional study by Kanders et al. (1988) on 60 
premenopausal women, with stable endocrine status, found that although there was not a 
significant linear relationship between lumbar spine BMD and calcium intake, when the 
sample of women were divided into those with a calcium intake above the RDA (800 
mg/d) and those with a calcium intake below the RDA, both vertebral and radial BMD 
were significantly greater in the high calcium intake group. Although Grimston et al. 
( 1990b) found that current calcium intake was not shown to be related to current BMD, 
they did find a positive relationship between estimated history of calcium intake during 
the formative years of bone growth, and current BMD of the lumbar spine. Calcium 
requirements increase with the onset of puberty at which time calcium intake is often 
reduced (Heaney, 1982a), placing the individual at risk of inadequate calcium retention 
resulting in reduced peak bone mass and the subsequent risk of developing osteoporosis 
in later life. Other studies have found no association between calcium intake and BMD 
and/or BMD changes (Mazess and Barden, 1991; Micklesfield et al., 1995). 
It is important to remember that effective calcium intake is not only a result of adequate 
calcium in the diet. A study by Heaney and Recker ( 1982b) found that the most 
prominent determinant of calcium balance was calcium absorption, with dietary calcium 
intake being the next prominent factor. Thus, factors such as absorption efficiency, 
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retention efficiency, various nutrient-nutrient, drug-nutrient, and disease-nutrient 
interactions all affect the availability and utilization of the calcium taken in in the diet 
(Heaney, 1982a). Therefore, in healthy women excessive intake of certain nutrients such 
as nitrogen, phosphorus and caffeine, as well as the abuse of certain drugs such as 
diuretics, antacids and alcohol, may impact negatively on calcium absorption. 
c. Vitamin D and other nutrients 
Calcium balance (body retention) is determined not only by calcium intake and net 
calcium absorption but also by urinary excretion (Matkovic et al., 1990). Urinary 
calcium does not necessarily increase with an increase in calcium intake, so an increased 
intake is still a major determinant of calcium balance. However, not only current calcium 
intake, but also Vitamin D intake has been identified as a major determinant of calcium 
balance in sedentary women (Fehily et al., 1992). Vitamin D deficiency is one of several 
factors that decrease dietary calcium absorption from the gut, and increase excretion of 
calcium in the urine or faeces or both. This may be due to a fall in circulating calcitriol or 
1,25 dihydroxyvitamin D3 [1,25(0H)2D3] levels, the hormonal form of Vitamin D. Two 
schools of thought exist regarding the mechanism of how this occurs (Heaney et al., 
1982a). One interpretation assumes that the reduced secretion of calcitriol which occurs 
with age, deficiencies of gonadal steroids, or other factors, results in a malabsorption of 
calcium and thus reduced serum calcium. This stimulates an increase in PTH secretion in 
order to increase the renal production of calcitriol, however the elevated levels of PTH 
result in bone resorption and consequent bone loss. The other hypothesis assumes an 
imbalance between bone resorption and bone formation due to factors such as reduced 
physical activity and hypoestrogenism. Because calcium released from the skeleton is 
greater than calcium taken up by the skeleton, PTH secretion, as well as calcitriol 
synthesis, are reduced. The result will then be reduced calcium absorption from the 
skeleton. Heaney et al., ( 1982a) concluded however that both these hypotheses may in 
fact be correct and applicable to different individuals. 
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Some research has found that a high protein intake in excess of dietary need may enhance 
bone loss through increased urinary calcium excretion due to reduced retention of 
absorbed calcium (Heaney and Recker, 1982b ). There is also a strong relationship 
between caffeine consumption and bone mineral density, as a high caffeine intake has 
been found to increase the risk of osteoporotic fractures in middle-aged women as a result 
of increased urinary calcium excretion (Hernandez-Avila et al., 1991 ). Other dietary 
factors that may influence calcium balance include nitrogen and phosphorous (Heaney et 
al., 1982b ). The intake of these variables is strongly related to each other, therefore an 
increase in the intake of one will result in an increase in the intake of the other factor. For 
example, with an increase in the intake of dairy products, there is an increase in the intake 
of calcium, nitrogen and phosphorus. It seems that increasing phosphorous alone has no 
influence on calcium balance, however nitrogen and caffeine have a negative effect on 
calcium balance due to an increase in urinary calcium excretion, rather than calcium 
absorption efficiency. The study concluded that a 50% increase in nitrogen intake above 
the group mean intake value (10.9 ± 2.5 g/d), an intake which is not extreme, would be 
predicted to result in calcium balance shift of -0.032 g/d, while for caffeine, the 
corresponding calcium balance shift would be predicted to be -0.006 g/d. A negative 
balance of 0.040 g/d may explain the 1-1.5% loss in skeletal mass per year noted in 
premenopausal women. Large amounts of dietary fibre have also been found to have an 
affect on calcium balance, however it is unlikely that the fibre content of most Western 
diets is sufficient to cause negative calcium balance, however some individuals may be at 
risk (Heaney et al., 1982a). 
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d. Nutrition and hormones 
Nutrient status may also affect hormonal influences on the remodeling process.(Dalsky, 
1990). Under conditions of inadequate calcium intake, blood calcium levels are 
maintained through PTH stimulation of calcium withdrawal from bone, resulting in an 
increase in remodeling activity and a negative bone balance. Alternatively, estrogen 
withdrawal produces an increase in the calcium intake requirement due to lower intestinal 
absorption and increased urinary calcium loss (Heaney et al., 1982a; Drinkwater et al., 
1984; Nelson et al., 1986). The calcium intake levels recommended by the Consensus 
Conference on Osteoporosis conducted by the National Institutes of Health are higher 
than the previous RDA of 800 mg/d. Rather 1 000 mg/d for men and premenopausal 
women and 1 500 mg/d for estrogen-deficient women has been recommended. 
C.vi Combination of the factors 
A combination of the various factors and their influence on BMD must be considered. 
However, although there is some interaction between the three major factors that 
influence bone health namely, physical activity, hormonal status and nutrition, each 
should be seen as playing an independent role in the attainment of bone mass, and neither 
is more important than the others. Research using an avian model has provided evidence 
to suggest that exercise training in the presence of low calcium intake, may minimise the 
adaptation of the bone to exercise training (Lan yon, 1986). During calcium deficiency, 
physical activity resulting in mechanical loading should decrease resorption and turnover, 
however when calcium deficiency is severe, physical activity may not be sufficient to 
prevent a negative calcium balance from developing. In contrast, some research has 
suggested that adequate levels of both will produce maximal bone mineralisation, which 
will not be increased further even by higher calcium intakes or physical activity levels 
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(Halioua and Anderson, 1989). There may also be an additive effect between exercise 
and calcium as some research has shown a significant difference in mean vertebral BMD 
between women who had both an active life-style and high calcium intake, and those who 
were both inactive and calcium deficient (Halioua and Anderson, 1989). However, other 
research has found no significant interaction of calcium and exercise with BMD, although 
results did show a tendency for negative bone changes over 2 years in the least active 
subjects (Mazess and Barden, 1991 ). 
It has already been established that women who develop amenorrhea as a result of 
excessive exercise have reduced bone mass (Cann et al., 1984; Drinkwater et al., 1984; 
Drinkwater et al., 1990; Armamento-Villareal et al., 1992; Micklesfield et al., 1995). 
Estrogen may therefore be potentially more powerful in determining bone mass than 
physical activity, even in premenopausal women (Aloia et al., 1988), unless very high 
impact exercise is performed regularly for several hours per day such as in elite gymnasts 
(Robinson et al., 1995). However, although bone mineral density is compromised in 
women with exercise-induced amenorrhea, it is higher than in women with other causes 
of amenorrhea eg. oophorectomy (Genant et al., 1982; Young et al., 1994). Similarly, 
Marcus et al. ( 1985) showed that although amenorrheic runners had bone density which 
was lower than eumenorrheic women and age-matched controls, it was higher than in 
runners with secondary amenorrhea who were less physically active. Thus, the 
mechanical loading characteristics of exercise may have some protective effect on bone 
in the presence of menstrual irregularity and may reduce the impact of amenorrhea on 
bone mass (Jonnavithula et al., 1993), particularly if adequate calcium is absorbed. 
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D. INTERVENTION 
Most of the factors which influence BMD and which were discussed above are easy to 
manipulate, by either dietary supplementation or pharmacological intervention with 
hormone replacement therapy. It is therefore necessary to identify populations at risk of 
premature bone loss and to base treatment and education programmes on sound scientific 
evidence. Although interventions may seem insignificant, such as the intake of a 
particular dietary variable, it has been shown that a high protein intake can result in an 
average negative calcium balance of 84 mg/d which is greater than the negative calcium 
balance of 40 mg/d which has been calculated to result in a loss in skeletal mass of 10-15 
% per decade (Heaney and Recker, 1982). This alone, or in combination with other 
factors, will have a large impact on the risk of developing osteoporosis in later life. In 
contrast, findings from a study by Recker et al. (1992a) in which it was determined that 
bone gain continues in women up until a point close to 30 years of age, suggests that 
fracture risk late in life can be reduced significantly by modest increases in physical 
activity and calcium intake under the age of 30 years. 
For highly competitive amenorrheic premenopausal athletes who may be resistant to 
reducing training and gaining weight to regularise their menstrual cycles, estrogen 
replacement therapy is recommended. Although not yet scientifically proven it is perhaps 
prudent to institute estrogen therapy at an early stage since it is still unknown whether or 
not bone loss due to prolonged menstrual irregularity can ever be fully regained prior to 
menopause. Until data are available to definitely show that women in their late 
premenopausal years who had menstrual irregularity in their twenties, can regain their 
bone mass, it must be assumed that such women are at risk of developing osteoporosis in 
later life. However, the data does suggest that regular weight-bearing exercise or weight-
training, or both, in conjunction with adequate calcium intake should benefit the 
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attainment of peak adult bone mass in regularly menstruating women who have a family 
history of osteoporosis or other significant risk factors for low bone mass. 
However, no controlled intervention trials have done in amenorrheic women to confirm 
the benefits of weight-bearing exercise, an increase calcium intake and estrogen therapy. 
Neither have any studies investigated bone mineral density changes in athletic women in 
their mid-thirties to forties, to determine whether the effects of prior menstrual 
irregularity are still significant in that late premenopausal period. 
Therefore the main aims of this thesis were to: 
(i) determine whether mature women athletes who have experienced prior menstrual 
irregularities are still at risk of a reduced bone mineral density in the late premenopausal 
period; 
(ii) compare risk factors for reduced bone mineral density between exercising women 
with a history of menstrual irregularity, exercising women with no history of menstrual 
irregularity, and sedentary controls with no history of menstrual irregularity. 
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CHAPTER2 
Bone Mineral Density in mature, premenopausal, ultramarathon runners. 
STUDY 1 
This is a previously published unit in Medicine and Science in Sports and Exercise Vol 
27, No. 5, pp. 688-696, 1995. 
1. INTRODUCTION 
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It is now well established that amenorrheic athletes have low vertebral bone density 
(Cann et al., 1984; Drinkwater et al., 1984; Drinkwater et al., 1986; Marcus et al., 1985; 
My burgh et al., 1983; Nelson et al., 1986; Nilson and Westlin, 1971). As a result of the 
association between osteopenia and an increased incidence of stress fractures in athletes 
(Myburgh et al., 1990), and since osteoporosis may be a potential long-term complication 
(Marcus et al., 1985), there has been a growing interest in the identification of the 
etiological factors associated with this form of osteopenia. 
Bone mineral density in this population may be influenced by several variables such as 
current menstrual status, menstrual history, body mass, functional loading and calcium 
balance. Complex inter-relationships between these variables may exist. It has been 
suggested that physical activity, especially if it is weight-bearing, may act to increase 
BMD (Aloia, 1981; Marcus et al., 1985; Nilson and Westlin, 1971 ), and may therefore 
offset bone loss induced by oligo/amenorrhea. However, large training volumes and 
inadequate energy intake, are also associated with oligo/amenorrhea. However, large 
training volumes and inadequate energy intake, are also associated with oligo/amenorrhea 
38 
(Loucks, 1990; Rippon et al., 1988), low endogenous estrogen concentrations 
(Drinkwater et al., 1986), low calcium intake (Nelson et al., 1986) and consequently, 
osteopenia (Lutter, 1983). Some previous studies have found that both amenorrheic and 
oligomenorrheic runners ran greater distances each week than eumenorrheic runners 
(Drinkwater et al., 1984), while other studies failed to demonstrate differences in training 
patterns between these groups (Marcus et al., 1985). Some (Drinkwater et al., 1984; 
Marcus et al., 1985; Nelson et al., 1986), but not all, studies have shown that amenorrheic 
runners have a significantly lower reported energy intake than do eumenorrheic runners. 
The long-term consequences of oligo/amenorrhea are still unknown, as most of the 
studies to determine the effect of amenorrhea on BMD in women athletes have been 
performed on young subjects (Drinkwater et al., 1984; Drinkwater et al., 1986; 
Drinkwater et al., 1990; Marcus et al., 1985). The average age of the amenorrheic 
subjects used in these studies ranged from 20 to 27 years. Results from our laboratory 
have shown (Watkin et al., 1991) that dietary intakes did not influence menstrual function 
in mature, ultramarathon runners (average age 34 years), indicating that the risk factors 
for low BMD may be different in somewhat older athletes. Also, Drinkwater et al. (1986) 
showed that the osteopenia induced by amenorrhea is, at least partially, reversible in 
athletes who regained menses. Both the resumption of menstrual cycles and the increase 
in BMD in these athletes followed a change in a variety of interrelated risk factors for low 
BMD, namely a decrease in training, an increase in body weight, and an increase in 
consumption of dairy products or calcium supplements or both. This may indicate that 
somewhat older athletes with a prior history of oligo/amenorrhea may be at less risk for 
osteoporosis in later life than previously expected. However, this is as yet not 
substantiated by sufficient scientific evidence. 
Therefore the aim of this study was to relate risk factors for a reduced bone mineral 
density, especially delayed menstrual cycles, to actual BMD, in a group of older, 
premenopausal female ultramarathon runners. 
11. HYPOTHESIS OF STUDY 1 
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The hypothesis of this study was that any history of menstrual dysfunction will influence 
lumbar spine bone mineral density. 
iii. MATERIALS AND METHODS 
All women, between 25 and 39 years of age, who had entered a 56 km ultramarathon road 
race and were living in the Cape Town metropolitan area and surrounding rural districts, 
were contacted and invited to complete a questionnaire. Eighty of the 152 women 
returned the questionnaire. Forty women were randomly selected from these respondents 
and were invited to participate in the study. The study was approved by the Ethics and 
Research Committee of the University of Cape Town Medical School, and written 
informed consent was obtained from all subjects. 
Subject details including age, height, highest and lowest adult weights, as well as training 
histories, menstrual history, and use of oral contraceptive medications, were obtained 
from an initial questionnaire. Subjects who were currently taking oral contraceptives 
(n=15) were excluded from further analysis. Of these 15 subjects, only 3 had a prior 
history of oligo/amenorrhea. Body Mass Index and change in Body Mass Index (DBMI) 
were calculated from the following equations: 
BMI =mass* heighr2 (kg.m-2) 
DBMI = highest adult BMI - lowest adult BMI (kg.m-2) 
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Body composition was measured according to the method of Durnin and Wormesley 
(1974). Skinfold measurements were taken on the right side at the triceps, biceps, 
subscapular and suprailiac sites. Fat mass,% body fat and fat free mass were calculated. 
Somatotype was assessed using the Heath-Carter method (Heath and Carter, 1967). 
Daily energy expenditure (MJ.d-1) was estimated for each of the subjects (Blair et al., 
1985). All the subjects also completed a 3-day dietary record for two week days and one 
week-end day. These data were analysed using the food quantities tables of the National 
Research Institute for Nutritional Diseases (Parow, South African Medical Research 
Council Publications Unit, 1986) and a computerised dietary analysis programme (Floro 
Diet Data Programme, P.O. Box 6138, Durban, 4000). Total energy (kJ), calcium (mg), 
phosphorus (mg), protein (g), fat (g), carbohydrate (g), and dietary fibre (g) intakes per 
day were determined. 
Venous blood samples were drawn during the mid- to late-follicular phase of the 
menstrual cycle (days 8 - 12) and serum estradiol concentrations were determined by 
means of a specific radio immunoassay performed on ether extracts of the plasma 
samples. The extraction and assay procedures are modifications to the methods of 
Abraham et al. (1976). A 2 hour urine collection was obtained from each subject for the 
first two hours after waking and analysed via atomic absorption spectrometry for urinary 
calcium concentration (Willis, 1961 ). 
An osteodensitometry scan was performed in the Department of Nuclear Medicine, 
Groote Schuur Hospital using a Ho logic QDR-1000 (version 4.20) dual energy x-ray 
bone densitometer (Ho logic Inc., Waltham, Massachusetts). Scans were made of the 
lumbar spine and the left proximal femur. Average bone mineral densities (g.cm-2) were 
determined for lumbar vertebrae 1 through 4 and the total proximal femur, Ward's 
triangle, femoral neck, greater trochanter, and the intertrochanteric space. 
During this period of the study the subjects were interviewed to obtain more detailed 
information concerning menstrual history and intake of dairy products during the 
following time periods: 13-20 yr.; 21-30 yr. and 31 to current age. Parity and 
breastfeeding details were also obtained by interview. The information was used to 
calculate the following: 
(i) Menstrual History Index (modified from Grimston et al. (1990a)) was calculated to 
determine the estimated number of periods per year since age 13: 
Menstrual History Index= (1 l.5*R + 7*0 + 1.5* A)/(C-13) 
where: R= number of years ofregular menstrual cycles (defined as 10-13 
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menstrual periods per year and assuming an average of 11.5 periods.yr-I); 
0= number of years of oligomenorrhea ( defined as 4-9 menstrual periods per year 
and assuming an average of7 periods.yr-I); 
A= number of years of amenorrhea ( defined as 0-3 menstrual periods per year and 
assuming an average of 1.5 periods.yr-I); 
C= current age. 
(ii) The Menstrual History Index was then divided into the estimated number of periods 
per year for the following three time periods: 
- 13-20 years of age 
- 21-3 0 years of age ( or 21-present age) 
- 31-39 years of age (or 31-present age). 
As above, it was assumed that eumenorrhea = 11.5 menstrual cycles per year; 
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oligomenorrhea = 7 menstrual cycles per year; and amenorrhea= 1.5 menstrual cycles per 
year. 
(iii) Dairy product intake was reported as the estimated number of portions consumed per 
week during junior school, high school, on leaving school, and over the past year. One 
portion was equivalent to one cup of milk, 175 ml of yoghurt, a rounded scoop of ice-
cream, a 250 g tub of cottage cheese, and a cheese meal or sandwich. 
Data analysis 
Data are presented as means± standard deviations (SD). Unpaired Student's t-tests were 
performed to compare data from runners who had always had regular menstrual cycles 
(R, n=15), and those with current or previous menstrual irregularity (OA, n=lO), defined 
for this study as oligo/amenorrhea (0-9 periods.yr-I). The Kolmogorov Smimov 2-
sample test was performed for the following non-parametric variables: estimated number 
of periods per year between the age of 21 and 30 years, and above 30 years of age. 
Kruskal-Wallis tests were performed to compare the BMD data of three groups after 
dividing the subjects into those women who had always had regular menstrual function 
(R), those who had oligo/amenorrhea in the past but who had now resumed regular 
menstrual cycles (CR; n=4), and those women who were currently oligo/amenorrheic 
(COA; n=6). Kruskal-Wallis tests were also performed to compare the BMD data of 
three groups after dividing the subjects into those women who had always had regular 
menstrual cycles (R), those who had a history of oligomenorrhea with no history of 
amenorrhea (HO; n=4), and those women who had a history of either amenorrhea or both 
amenorrhea and oligomenorrhea (HOA; n=6). Pearson-product moment correlation 
coefficients were calculated to determine which variables were significantly correlated 
with BMD, as well as between selected variables to determine the possibility of an 
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indirect effect on BMD. Multiple linear regression was performed to develop prediction 
equations for bone mineral density of the lumbar spine and the left hip. This was done in 
several steps: first, five variables were entered into a stepwise selection for each of the 
four main categories, namely, physical characteristics (mass; height; fat mass; BMI; 
DBMI), menstrual variables (estimated no. periods.yr-I for 13-20 yr of age and 21-30 yr 
of age; MHI; menarche; years amenorrheic ), training variables (training index; estimated 
energy expenditure per day; personal best race time: 56 km and 21.1 km; years of 
marathon training) and dietary variables ( calcium index, total energy intake, calcium 
intake, fibre intake, urinary calcium). The variables with the best F-values from each of 
the four main categories were then entered into another stepwise selection to determine 
the best overall predictor of BMD at the lumbar spine and the femoral neck. 
Subsequently Pearson-product moment correlation coefficients were also calculated to 
determine the relationships between LS BMD and MHI, years of regular menstrual 
cycles, oligomenorrhea and amenorrhea in those 10 subjects with a history of menstrual 
irregularity. 
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IV. RESULTS 
Comparison of groups 
Fifteen subjects had always been regular (R, 10-13 periods.yr-I) and 10 had a history of 
oligo/amenorrhea, (OA, 0-9 periods.yr-I). Subjects ranged in age from 29 to 39 years of 
age. The regular (R) and oligo/amenorrheic (OA) group did not differ in age (R: 36 ±3 
vs. OA: 35 ±4 yr.), (mean± SD), body mass (R: 58 ±8 vs. OA: 57 ±8 kg), body mass 
index (BMI) (R: 21.4 ±2.4 vs. OA: 20.9 ±2.0 kg.m-2) or estimated body fat (R: 29 ±4 vs. 
OA: 29 ±4 %) (Table 2.1). The DBMI (highest - lowest adult BMI) was also not 
significantly different, although the OA group tended to have a greater range of values. 
Other anthropometric measurements were also similar in both groups: endomorphy (R: 
4.4 ±1.3 vs. OA: 4.6 ±1.3); mesomorphy (R: 3.5 ±1.1 vs. OA: 3.6 ±1.1); ectomorphy (R: 
2.9 ±1.3 vs. OA: 3.1 ±1.0). Current weekly training distances (R: 68 ±21 vs. OA: 76 ±33 
km.wk-I) and years of running training (R: 4.1 ±2.3 vs. OA: 3.8 ±3.6 yr.) were also 
similar between the two groups (Table 2.1). Total daily estimated energy expenditure (R: 
14 ±3 vs. OA: 15 ±3 MJ.d"1 ) was similar between Rand OA. 
Of the 10 subjects with a history of oligo/amenorrhea (OA), 6 were still currently 
irregular, while 4 had regained regular menstrual cycles. Of these 4, 3 had regained 
regular menses greater than 10 years prior to the study and the other subject had regained 
regular menses 4 years prior to the study. OA subjects had a history of amenorrhea for a 
total of 3 .2 ±3. 7 yr (mean ±SD) and oligomenorrhea for 2. 7 ±2.2 yr. The MHI was 
significantly lower in OA than R (R: 11.6 ±0.6 vs. OA: 9.4 ±2.1, p<0.01). Four of the 
OA subjects had a MHI score between 6 and 7. They had all had amenorrhea, ranging 
from 3-7 years in total. However the 2 with the lowest BMD values also had a history of 
oligomenorrhea for 5-6 years. The MHI of OA subjects was significantly different from 
R subjects between age 21 and 30, and above age 30 years (both p<0.0001) (Table 2.2). 
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Parity and months of breastfeeding were similar in Rand OA (R: 1.6 ±1.0 vs. OA: 1.2 ± 
1.7 children and R: 6.2 ±7.9 vs. OA: 10.7 ±14.3 months). Only one woman was currently 
breastfeeding her 3 year old child. No woman had been pregnant for at least 3 years, and 
the age since the last pregnancy ranged between 3 and 16 years. The normal range of 
estradiol, during the follicular phase of the menstrual cycle, is 100-700 pMou-1, for this 
laboratory. Only two women had levels below the minimum, and thus had 
hypoestrogenic amenorrhea at the time of the trial. The other 4 women in the currently 
oligo/amenorrheic group were currently oligomenorrheic. Mean estradiol levels were 
not significantly different between the two groups (see Table 2.2). 
The mean BMD of the lumbar spine in this sample was 1.032 ±0.105 g.cm-2 and that of 
the left proximal femur was 0.935 ±0.118 g.cm-2. The range ofBMD values for the 
lumbar spine varied from 84% to 112% of age-matched normals (reference curve for 
American females, Ho logic QDR-1000, October 1984). The range of BMD values for 
the left hip varied from 86% to 124% of age-matched normals (reference curve for 
females, Hologic QDR-1000, October 1984). The mean BMD of the lumbar spine for R 
was 1.088 ±0.069 g.cm-2 and for QA was 0.946 ±0.098 g.cm-2 (p<0.001), and BMD of 
the left proximal femur was 0.964 ±0.133 g.cm-2 for Rand 0.889 ±0.083 g.cm-2 for OA 
(p=0.07). Neither total proximal femoral BMD, nor BMD at the femoral neck, trochanter 
or Ward's triangle were different between the two groups (Table 2.3). 
After division of the OA group into those who were currently oligo/amenorrheic (COA) 
and those who were currently regular (CR) but previously oligo/amenorrheic, we found 
that BMD of the lumbar spine was significantly lower in COA subjects compared to R 
(R:1.088 ±0.069 vs. COA: 0.923 ±0.069 g.cm-2; p<0.001), as well as showing a similar 
trend in CR compared to R (R: 1.088 ±0.069 vs. CR: 0.982 ±0.136 g.cm-2; p<0.07). 
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Body mass was not significantly different between these groups (R: 58.3 ±7.9 vs. CR: 
54.5 ±9.3 vs. COA: 59.1 ±6.7 kg). Neither was DBMI different between these groups (R: 
4.1 ±2.6 vs. CR: 4.0 ±1.4 vs. COA: 5.7 ±4.3 kg.m-2). 
The OA subjects were also subdivided into those who had a history of oligomenorrhea, 
but no history of amenorrhea (HO) and those who had a history of either amenorrhea or 
both oligomenorrhea and amenorrhea (HOA). Lumbar spine BMD was not different 
between HO subjects (0.953 ±0.024 g.cm-2) and HOA subjects (0.942 ±0.131 g.cm-2). 
Both these groups were significantly lower than R: those with a history of 
oligomenorrhea, but no history of amenorrhea (HO; p<0.005) and those with a history of 
amenorrhea (HOA; p<0.005) (see Fig. 2.1). 
There were no significant differences between groups for current reported daily energy 
and calcium intakes (R: 7164 ±1894 vs. OA: 6479 ±1557 kJ.d-1 and R: 709 ±459 vs. OA: 
774 ±350 mg.ct-I) (Table 2.4), or for any other measured component of the diet, except 
for fibre intake which was significantly higher in OA (p<0.05). Urine calcium excretion 
measured from a 2-hour morning urine collection, was not different between the two 
groups (see Table 2.4). 
Analysis by correlation 
Lumbar spine BMD for the whole sample of women did not correlate with the total 
number of years of amenorrhea, but correlated significantly with the total number of 
years of oligomenorrhea (p<0.01, r= -0.58), total number of years ofregular menstrual 
cycles (p=0.01, r=0.50) and with the overall MHI (p<0.0005, r= 0.67) (see Fig. 2.2). 
Lumbar spine BMD for the whole sample of women also correlated significantly with the 
estimated number of periods per year from (a) 13-20 years of age (p<0.05, r=0.39), (b) 
21- 30 years of age (p<0.01, r=0.59), and (c) 31 to 39 years of age (p<0.01, r=0.52). No 
dietary, training or body composition variable correlated with lumbar spine BMD. 
Femoral BMD was significantly correlated with BMI (p<0.05, r=0.43), but no other 
variable. 
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Despite small subject numbers and low statistical power, lumbar spine BMD of those 
women with a history of menstrual irregularity correlated significantly with the total 
number of years of oligomenorrhea (p<0.05, r= -0.53) and the years of regular menstrual 
cycles (p<0.05, r= 0.60). The correlation between LS BMD and the overall MHI 
(r= 0.48) approached significance, but LS BMD did not correlate with the total number of 
years of amenorrhea (r= -0.38) (see Fig. 2.3). 
In addition to determining those factors directly associated with BMD, we also 
determined which risk factors for low BMD were also related to each other. The MHI 
was negatively correlated with total energy expenditure per day (p<0.01, r= -0.51) (see 
Fig. 2.4 ), indicating that a history of fewer menstrual cycles per year was associated with 
higher activity levels. Total energy expenditure was also positively correlated with BMI 
(p<0.01, r= 0.53) and DBMI (p<0.001, r= 0.62), indicating that those subjects who were 
currently heavier relative to their height, or whose body mass had fluctuated to the largest 
extent in the past, were physically more active. 
The variables with the best F-values for the stepwise multiple regressions performed by 
category were entered into the final stepwise multiple regression in order to determine the 
best single predictor of LS BMD. These variables were: MHI, BMI, DBMI and 
mesomorphy. The best single predictor of the BMD of the lumbar spine was MHI 
(stepwise multiple regression: r2=0.45, p<0.001). The formula which best predicted 
variability in BMD of the lumbar spine was: 
BMD lumbar spine= (MHI * 0.04) + 0.59 (r2 = 0.45) 
Table 2.1 Physical characteristics and training variables of ultramarathon runners who 
had always had regular menstrual cycles and who had either current or prior 
oligo/amenorrhea, or both. 
Always Current or prior 
regular oligo/amenorrhea 
(n=15) (n=lO) 
Age (yr) 35.5 ±3.2 34.8 ±4.3 
Mass (kg) 58.3 ±7.9 57.2 ±7.7 
Height (cm) 165.2 ±6.5 165.4 ±6.8 
BMI (kg.m-2) 21.4 ±2.4 20.9 ±2.0 
DBMI (kg.m-2) 4.1 ±2.6 5.0 ±3.4 
Body fat(%) 29 ±4 29 ±4 
Fat mass (kg) 16.6 ±4.1 16.6 ±3.3 
Lean body mass (kg) 41.1 ±5.8 40.7 ±5.7 
Running training 
- minimum km.wk- I 44 ±14 58 ±29 
- maximum km.wk- I 68 ±21 76 ±33 
Personal best race time (min) 
56km 334 ±18 322 ±42 
21.1 km 104 ±8 98 ±12 
Marathon training (yr) 4.1 ±2.3 3.8 ±3.6 
Energy expenditure (MJ.d-1) 14 ±3 15 ±3 
Data are presented as means ±SD. Statistical analysis: unpaired t-test. 
Abbreviations: BMI = Body Mass Index; DBMI = Delta Body Mass Index 
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Table 2.2 Variables related to the past and present menstrual and reproductive status of 
ultramarathon runners who had always had regular menstrual cycles and who had either 
current or prior oligo/amenorrhea, or both. 
Menarcheal age (yr) 
Always 
regular 
(n=15) 
12.9 ±1.3 
11.6 ±0.6 Menstrual History Index 
(periods.yr-1 since 13 yr) 
Estimated no. periods per year: 
13-20 yr of age 12.3 ±2.2 
21-30 yr of age# 11.5 ±0 
31-39yrofage# 11.5 ±0 (n=14) 
Total no. periods 261 ±42 
Years amenorrheic## 0 
Years oligomenorrheic## 0 
Serum estradiol (pMoU-1) 608 ±367 
Months of breastfeeding 6.2 ±7.9 
Number of children 1.6 ±1.0 
Current or prior 
oligo/amenorrhea 
(n=IO) 
13.0 ±1.8 
9.4 ±2.1 ** 
9.8 ±2.1 *** 
10.0 ±2.1 *** 
8.5 ±3.5 (n=8) *** 
209 ±66 * 
3.2 ±3.7 
2.7 ±2.2 
395 ±397 
10.7 ±14.3 
1.2 ±1.7 
Data are presented as means ±SD. Statistical analysis by unpaired t-test except for 
variables marked #: Kolmogorov test and ##: no statistical test. 
* p<0.05 
** p<0.01 
*** p<0.001 
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Table 2.3 Bone mineral densities of ultramarathon runners who had always had regular 
menstrual cycles and who had either current or prior oligo/amenorrhea, or both. 
Always Current or prior 
regular oligo/amenorrhea 
(n= 15) (n=lO) 
Lumbar Spine (g.cm-2) 1.088 ±0.069 0.946 ±0.098* 
Femur: 
Neck (g.cm-2) 0.872 ±0.110 0.817 ±0.088 
Trochanter (g.cm-2) 0.740 ±0.121 0.671 ±0.057 
Intertrochanter (g.cm-2) 1.115 ±0.150 1.032 ±0.l 08 
Total hip (g.cm-2) 0.964 ±0.133 0.889 ±0.083 
Wards triangle (g.cm-2) 0.702 ±0.133 0.673 ±0.085 
Data are presented as means ±SD. Statistical analysis: unpaired t-test. 
* p<0.001 
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Table 2.4 Dietary intake and history of dairy product intake of ultramarathon runners who 
had always had regular menstrual cycles and who had either current or prior 
oligo/amenorrhea, or both. 
Always Current or prior 
regular oligo/amenorrhea 
(n=15) (n=lO) 
Total energy (kJ.d-1) 7164 ±1894 6479 ±1557 
Calcium (mg.d-1) 709 ±459 774 ±350 
Phosphorus (g.d-1) 1089 ±409 1022 ±381 
Protein (g.d-1) 65 ±21 52 ±17 
Fat (g.d-1) 69 ±30 51 ±25 
Carbohydrate (g.d-1) 172 ±57 198 ±35 
Fibre (g.d-1) 14 ±6 19 ±6 * 
Urinary calcium 
(mmol.2 hr 1) 0.25 ±0.19 0.21 ±0.14 
Portions of dairy products per week: 
Past year 5.2 ±4.6 7.7 ±5.5 
On leaving school 5.9 ±8.0 6.3 ±6.3 
During high school 6.5 ±5.21 7.2 ±5.8 
During junior school 7.5 ±5.7 6.1 ±4.5 
Total portions/4 6.2 ±4.7 6.6 ±4.5 
Data are presented as means ±SD. Statistical analysis: unpaired t-test. 
* p<0.05 
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Fig 2.1: Lumbar spine bone mineral density (BMD) of premenopausal long distance runnen who were divided 
into 3 groups according to previous menstrual status. Data presented as mean :ts». Statistical analysis by 
Kruskal-Wallis test Subjects who had a history of oligomenorrhea with no history of amenorrhea (HO; n=4) 
were significantly(• p<0.005) lower than regular subjects (n=15). Subjects who had a history of either 
amenorrhea or both amenorrhea and oligomenorrhea (HOA; n=6) were also significantly (• p<0.005) lower 
than regular, but not different from HO. 
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since age 13 years. A Pearson-product moment correlation coefficient of r=0.67 was highly significant 
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1v. DISCUSSION 
The major contributions of this study were to show that in mature, premenopausal, long 
distance runners (i) a history of oligo/amenorrhea influences present bone mineral density 
(BMD) of the lumbar spine regardless of resumption of regular menstrual cycles in some 
subjects, and (ii) a history of oligomenorrhea, without any history of amenorrhea, is 
significantly related to low lumbar spine BMD. 
These data were collected from a cross-sectional sample of endurance trained women. 
When interpreting the data, the cross-sectional nature of the study must be taken into 
consideration. However, several previous studies which have also compared BMD of 
groups of runners on a cross-sectional basis have provided important insights into factors 
related to premature osteopenia in athletes (Cann et al., 1984; Drinkwater et al., 1984; 
Marcus et al., 1985; Drinkwater et al., 1990; Myburgh et al., 1990; Myburgh et al., 1993). 
The athletes recruited for this study were generally older, heavier and "slower" than the 
subject samples used in other similar studies. Although all the women had completed an 
ultramarathon there was a large range in mass, % body fat and race times between the 
athletes. Few of the subjects were training at a competitive level and there was no 
selection criteria based on performance as was used in the study by Marcus et al. ( 1985) 
in which all the subjects had to have completed a marathon race within 3 hours as well as 
running distances totalling more than 65 km/week. Average % body fat and weight of the 
amenorrheic subjects in the Marcus et al. (1985) study was 10.0 ± 1.1 % and 53.8 ± 1.6 kg 
respectively, while the subjects with current or prior oligo/amenorrhea in this study had 
an average% body fat of 29.0 ± 4% and average weight of 57.2 ± 7.7 kg. Although 
personal best 10 km racing times were not recorded in this study, personal best race time 
for a half marathon of 104 ± 8 mins and 98 ± 12 mins for eumenorrheic and 
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oligo/amenorrheic runners were obtained. Extrapolation of the personal best 10 km times 
of eumenorrheic and amenorrheic athletes in a study by Drinkwater et al. (1984) of 46 
±1.5 mins and 42 ± 5 mins respectively would be generally faster than the athletes in our 
study. 
Many studies have found menstrual irregularity, particularly amenorrhea, to be associated 
with low lumbar spine BMD (Cann et al., 1984; Drinkwater et al., 1984; Drinkwater et 
al., 1990). In our study only 2 of the OA group (20%) were currently amenorrheic and 
hypoestrogenic, 4 were oligomenorrheic ( 40%) and 4 had resumed regular menstrual 
cycles (40%); however lumbar spine BMD of the OA group was still significantly lower 
than that of the R group. The longitudinal study of Drinkwater et al. (1986) showed that 
resumption of menses in previously amenorrheic athletes is beneficial to lumbar spine 
BMD. Our cross-sectional data indirectly supports this evidence, since the lumbar spine 
BMD of our currently regular subjects was less different from R (p<0.07) than that of our 
currently oligo/amenorrheic subjects (p<0.001). However, further research is required 
since only 4 subjects in our study had resumed regular menses, one of whom still had a 
very low LS BMD despite four consecutive years of regular menses (See Fig. 2.2). 
Since the women in our study were all mature (29-39 years of age) and at, or close to 
their peak adult bone mass, our data can be interpreted to imply that the peak adult bone 
mass of the lumbar spine of women with a history of oligo/amenorrhea may never reach 
that of women who have always had regular menstrual cycles. It is not possible to 
distinguish whether this is due to bone loss or a lack of bone accretion, or both. 
Nevertheless, it has been suggested previously that factors which influence peak adult 
bone mass are similar to the risk factors for postmenopausal osteoporosis (Ott, 1990), 
including, in particular, a low level of circulating estrogen. To determine whether a 
history of amenorrhea is more detrimental to lumbar spine BMD than is a history of 
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oligomenorrhea, we divided the oligo/amenorrheic group into those who had current or 
prior amenorrhea (HOA) and those who had current or prior oligomenorrhea, but no 
history of amenorrhea (HO). There was no difference in the lumbar spine BMD between 
the HOA and HO groups and they were both highly significantly (p<0.005) (see Fig. 2.1) 
lower than the group who had always had regular menstrual cycles. Therefore, a history 
of oligomenorrhea should not be considered to be less detrimental to lumbar spine BMD 
than a history of amenorrhea. 
There was a large difference between subjects in the length of time of oligo/amenorrhea 
which ranged from 1 to 13 years. We, therefore, pooled all the athletes into one group 
and related their BMD and risk factors for bone loss to their overall Menstrual History 
Index. The Menstrual History Index (MHI) is a measure of the average number of 
periods per year from age 13 to current age. As such it provides a numerical score which 
is influenced by the number of years of amenorrhea, oligomenorrhea and regular 
menstrual cycles. In contrast to the menstrual index of Grimston et al. (1990a), it also 
takes into account the periods missed by subjects with a menarche later than age 13 years 
and the "additional periods" of those subjects with a menarche earlier than age 13 years. 
The range ofMHI scores for subjects in the R group was between 10.9 and 12.7 periods 
per year. This variation from the value of 11.5 (as the assumed number of periods per 
year during years reported as regular) is due to differences in menarcheal age. The range 
for subjects in the OA group was between 6.5 and 12.2 periods per year. This may be an 
overestimation, due to the assumptions of 1.5 and 7 periods per year for amenorrhea and 
oligomenorrhea respectively. However, the average for the oligo/amenorrheic group (9.4 
±2.1) cannot be considered to be particularly low. Hence, these subjects had all 
menstruated regularly for considerable periods of time. In this regard, it is interesting to 
note that menstrual regularity (MHI is an index of the number of periods experienced 
rather than the number of periods missed) correlated better (r=0.67) with LS BMD than 
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did either years of amenorrhea (not significant) or years of oligomenorrhea (r= -0.58). 
This result may have been influenced by the large number of subjects who had always 
had regular menstrual cycles. We therefore further investigated this important finding by 
correlating LS BMD with MHI and the components of MHI in only those subjects who 
had experienced oligo/amenorrhea. These results showed that in this small group of 
subjects, years of regular menstrual cycles and years of oligomenorrhea correlated 
significantly with LS BMD (p<0.05), but years of amenorrhea did not (see Fig. 2.3). 
Nevertheless, the influence of the time periods of regularity were not sufficient to bring 
their LS BMD to the same level as the R group, despite 3 of the subjects reporting 
oligo/amenorrhea greater than 10 years prior to the study. 
The MHI does not take into account at what age the menstrual irregularity was 
experienced or the time span since the last episode of menstrual irregularity. On average, 
the reproductive age of our subjects spanned over 20 years. We subdivided this age span 
into 3 time periods (13-20 yr of age, n=25 subjects; 21-30 yr, n=25 subjects and above 30 
yr, n=22 subjects) to determine whether or not oligo/amenorrhea during any particular 
age was more closely related to bone loss, than the overall MHI. The number of periods 
per year for the decades from age 20 years to 30 years, and from 30 years to 39 years (or 
to current age), were both significantly lower in OA than R. Although the correlations 
between BMD of the lumbar spine and the estimated number of periods per year for the 
three specified age ranges were good, the best simple correlation was between overall 
MHI and BMD of the lumbar spine. These data show that the entire menstrual history is 
the important determinant of LS BMD. 
Differences in LS BMD between groups Rand OA could not be ascribed to differences in 
parity or lactation history. Sowers et al. (1993) found that women who breastfed for 
more than 6 months had reduced BMD of the lumbar spine and the femoral neck, but that 
60 
BMD of the lumbar spine returned to baseline levels within 12 months of stopping 
breastfeeding. In the present study there was no relationship between months of 
breastfeeding and BMD of the lumbar spine or the proximal femur. However, a subject 
who had been breastfeeding continuously for 3 years and was also amenorrheic had the 
third lowest spinal BMD, suggesting that breastfeeding may have been another factor, in 
addition to her prior history of oligo/amenorrhea, explaining her particularly low BMD. 
Although menstrual history is the primary determinant of lumbar spine BMD, other 
variables such as body mass and weight-bearing may impact on BMD, particularly of the 
lower limbs. In the present study, the BMD of the left proximal femur tended to be lower 
in group OA vs. group R (p=0.07), but was not significantly correlated with any of the 
variables related to menstrual history, including the MHI. Although no significant 
difference was recorded between groups OA and R in the proximal femur and the other 
components of the hip, this may be due to small sample size, and therefore low statistical 
power, rather than the identity of the two groups. Recently, two studies have reported 
lower BMD in the femoral shaft of runners with amenorrhea or oligo/amenorrhea 
(Drinkwater et al., 1990; Myburgh et al., 1993). Drinkwater et al. (1990) reported lower 
femoral shaft BMD (measured below the lesser trochanter) in runners who had never had 
regular menstrual cycles and who had histories of oligomenorrhea or amenorrhea, or 
both. However, the difference was no longer significant when the data were corrected for 
lower body mass in the oligo/amenorrheic group. Nevertheless, Myburgh et al. (1993) 
reported lower proximal femur and mid-femoral shaft BMD in amenorrheic athletes who 
were very well matched with their control group for body mass. Major differences 
between the subjects in those studies and our current study, are the severity of menstrual 
irregularity, which was less severe in the current study, as well as the average body mass, 
which was higher in this study. Since femoral BMD was significantly related to BMI in 
our current study, it would appear that not only absolute body mass, but also body mass 
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relative to height are factors influencing lower limb BMD. Fat free body mass has 
previously been found to be the most significant predictor of bone mineral content in a 
group of athletes from a variety of sports (Heinrich et al., 1990), but was not related to 
femoral BMD in our study. Neither was mesomorphy, a measure of relative muscularity, 
related to BMD. This is probably because the subjects in our study were relatively 
homogenous compared with those in the study by Heinrich et al. (1990). The mechanism 
whereby higher body mass and BMI may influence BMD of the lower limbs is by 
imposing a larger mechanical load during weight-bearing exercise. According to Wolff s 
Law, bone mass will increase to meet the demands imposed by mechanical loading 
(Bassett, 1971 ), and longitudinal studies have now provided evidence that exercise 
training is, indeed, a stimulus for increasing bone mineral density (Dalsky et al., 1988; 
Margulies et al., 1986) and preventing bone loss (Krolner et al., 1983 ). In our subjects, it 
may be that the combination of relatively high body mass and weekly training load were 
sufficient to offset the influence of a history of oligo/amenorrhea on bone loss of the 
proximal femur. Further research is required to definitively prove this hypothesis. 
It has previously been shown that several different risk factors, including combinations of 
low BMI, large amounts of exercise, low energy intake and vegetarianism, have an 
additive negative effect on menstrual regularity (Myburgh et al., 1992). In the present 
study, we determined those variables which were statistically related to Menstrual History 
Index and thus also indirectly influenced lumbar spine BMD. Total estimated energy 
expenditure per day was significantly negatively correlated with the MHI (Fig. 4). This 
implies that those women who were currently more physically active had the longer 
history of oligo/amenorrhea and that the currently less physically active women were 
more likely to have had a longer history of menstrual regularity. Therefore, although 
weight-bearing activity is associated with increased bone density (Dalsky et al., 1990; 
Risser et al., 1990), excessive exercise may be associated with a higher incidence of 
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oligo/amenorrhea, resulting in reduced BMD. Thus, this study supports the concept that 
physical activity leading to high daily energy expenditure, coupled with insufficient 
energy intake, has an indirect effect on BMD through an influence on menstrual 
regularity. 
The positive correlation between total energy expenditure and DBMI (defined as highest 
adult BMI - lowest adult BMI), suggests that those subjects with the highest level of daily 
physical activity may be using exercise as a mechanism to control their body mass. In 
addition, it is highly likely that our subjects experienced a certain amount of energy drain, 
since the discrepancy between total energy expenditure and the reported energy intake 
was high. However, there was no relationship between% body fat and MHI, thus 
supporting the data of several other studies (Drinkwater et al., 1984; Loucks et al., 1984; 
Marcus et al., 1985; Sanborn et al., 1987; Rutherford, 1993; ) who found no association 
between athletic amenorrhea and body fat. The effect of exercise and dietary patterns on 
oligo/amenorrhea therefore does not necessarily manifest in a low % body fat, but may 
manifest in large fluctuations in body mass. 
In summary, this study of mature, premenopausal runners investigated the relative 
importance of various risk factors for osteopenia in predicting the current bone status. 
The data from this study indicate that a history of amenorrhea is less important than the 
overall history of oligomenorrhea and amenorrhea, as well as the number of years of 
regular menstrual cycles since age 13 years, in determining current bone status of the 
lumbar spine. Childbearing and breastfeeding histories were unrelated to BMD. 
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Although physical activity can be beneficial to bone health, this study suggests that even 
short episodes of oligo/amenorrhea are likely to have a negative influence on peak adult 
bone mass. Although these conclusions are significant in the understanding of 
osteopenia, they need to be substantiated by studies with larger sample sizes. 
ADDENDUM TO STUDY 1 
Fig 2.2 shows that only 4 of the 10 OA subjects had a low MHI. Four additional subjects 
were included with those in study 1 in order to determine if the conclusions made in Study 1 
would still hold with a larger number and a wider distribution of subjects in the OA group. 
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i MATERIALS AND METHODS 
Several women from a local running club who were participating in competitive marathon 
running were contacted and invited to take part in the study. Of the 25 women who were 
contacted, 5 women responded. It is not known whether the non-responders did not fit the 
inclusion criteria or whether they were unconcerned about their BMD, while those who did 
respond may have had musculoskeletal complaints that they wanted investigated. Inclusion 
criteria included i) being between the age of 29 and 45 yr, ii) being premenopausal, iii) not 
currently taking oral contraceptives and iv) having experienced current or previous menstrual 
irregulari~ies. Of these 5 women, only 4 women completed all the tests necessary for 
inclusion in the study. 
Information concerning menstrual history was obtained using the same forms as those filled in 
by subjects in study 1 in order to determine number of years of regular menstruation, number 
of years of oligomenorrhea, number of years of amenorrhea, and consequently the Menstrual 
History Index (MHI). All subjects had an osteodensitometry scan which was performed in the 
Department of Nuclear Medicine, Groote Schuur Hospital using a Hologic QDR-1000 
(version 4.20) dual energy x-ray bone densitometer (Hologic Inc., Waltham, Massachusetts). 
Scans were made of the lumbar spine and the left proximal femur. Average bone mineral 
densities (g.cm-2) were determined for lumbar vertebrae 1 through 4 and the total proximal 
femur, Ward's triangle, femoral neck, greater trochanter, and the intertrochanteric space. One 
subject did not return her questionnaire and was excluded from analyses. 
Data Analysis 
Unpaired Student's t-tests were performed to compare data from runners who had always had 
regular menstrual cycles (R, n= 15), and those with current or previous menstrual irregularity 
(OA, n=14). Pearson-product moment correlation coefficients were calculated to determine 
which menstrual variables were significantly correlated with lumbar spine BMD. These 
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menstrual variables were entered into a stepwise multiple regression to determine the best 
single predictor of lumbar spine BMD. Kruskal-Wallis tests were performed to compare the 
lumbar spine BMD data of three groups after dividing the subjects into those women who had 
always had regular menstrual function (R), those who had oligo/amenorrhea in the past but 
who had now resumed regular menstrual cycles (CR, n=6) and those women who were 
currently oligo/amenorrheic (COA, n=8). Kruskal-Wallis tests were also performed to 
compare the lumbar spine data of three groups who had always had regular menstrual cycles 
(R), those who had a history of oligomenorrhea with no history of amenorrhea (HO, n=7), and 
those women who had a history of either amenorrhea or both amenorrhea and oligomenorrhea 
(HOA, n=7). 
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11 RESULTS 
With the inclusion of the 4 extra subjects, data was now available on fifteen subjects who had 
always had regular menstrual cycles (R) and fourteen subjects with a history of 
oligo/amenorrhea (OA). Subjects ranged in age from 29-45 years. There was still no 
difference in age (R:35.5 ± 3.2 vs OA: 36.2 ± 5.1 yr), body mass (R: 58.3 ± 7.9 vs OA: 56.6 ± 
6.6 kg) and BMI (R: 21.4 ± 2.4 vs OA: 21.0 ± 2.0 kg.m-2) between the two groups, and none 
were significantly different from values in the original study. 
Of the four subjects who had been added to the oligo/amenorrhea (OA) group, two were still 
currently irregular, while two had regained regular menses. The overall MHI was 
significantly lower in OA than R (R: 11.6 ± 0.6 vs OA: 9.1 ± 2.2, p <0.001). 
The mean BMD of the lumbar spine for R was 1.088 ± 0.069 g.cm-2 and for OA was 0.951 ± 
0.085 g.cm-2 (p<0.001) and BMD of the left proximal femur was 0.964 ± 0.133 g.cm-2 for R 
and 0.891 ± 0.071 g.cm-2 for OA (p=0.08). 
Lumbar spine BMD for the whole sample of women (1.022 ± 0.10 g.cm-2) correlated 
significantly with overall MHI (p=0.0001, r=0.67) (see Fig 2.5), as well as total number of 
years of amenorrhea (p<0.01, r= -0.53), total number of years of oligomenorrhea (p=0.01, r=-
0.44), and total number of years ofregular menstruation (p<0.001, r=0.61). The best single 
predictor of the BMD of the lumbar spine was MHI (stepwise multiple regression: r2=0.45, 
p=0.0001). 
For the sample of women with a history of menstrual irregularity (OA: n=14), lumbar spine 
BMD did not correlate significantly with overall MHI (r=0.4 7), years of amenorrhea (r=-
0.41 ), or years of oligomenorrhea (r=-0.12), while there was a significant relationship between 
lumbar spine BMD and years ofregular menstruation (p<0.05, r=0.59)(see Fig 2.6). 
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After division of the OA group into those who were currently oligo/amenorrheic (COA) and 
those who were currently regular (CR) but previously oligo/amenorrheic, we found that BMD 
of the lumbar spine was significantly higher in the regularly menstruating runners (R) who 
had never experienced any menstrual irregularities compared to the COA subjects (R: 1.088 ± 
0.069 vs COA: 0.926 ± 0.060 g.cm-2; p=0.0001) as well as when compared to the CR 
subjects (R: 1.088 ± 0.069 vs CR: 0.985 ± 0.110 g.cm-2; p=0.0001). Lumbar spine BMD was 
not different between the two subgroups COA and CR. 
After division of the OA subjects into those who had a history of oligomenorrhea but no 
history of amenorrhea (HO) and those who had a history of either amenorrhea or both 
oligomenorrhea and amenorrhea (HOA), we found that BMD of the lumbar spine was 
significantly lower in HOA subjects compared to R (R: 1.088 ± 0.069 vs HOA: 0.938 ± 0.120 
g.cm-2; p<0.001), as well as in the HO group compared to R (R: 1.088 ± 0.069 vs HO: 0.965 
± 0.030 g.cm-2; p<0.001). Lumbar spine BMD was not different between the two subgroups 
HO and HOA (see Fig 2.7). 
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m DISCUSSION 
The results of the addendum are able to substantiate and solidify some of the major 
conclusion of study 1. The four additional subjects included provided a broader and more 
continuous spectrum of MHI values and any doubt that the findings of study 1 were a result of 
a small group of extremely low MHI values at the extreme of a wide distribution, can be 
extinguished. Similar subject numbers in the regularly menstruating group and the group with 
current and/or prior oligo/amenorrhea should prevent any bias that may have resulted from a 
larger number of subjects who had always had regular menstrual cycles in study 1. However, 
the possibility that the athletes with menstrual irregularity who responded may not reflect the 
overall population of athletes with menstrual dysfunction, but rather those who were 
concerned about their bone health, cannot been eliminated. 
Once again overall MHI correlated better with lumbar spine BMD (r=0.67, p=0.0001) than 
did any of the other menstrual variables viz. years ofregular menstrual cycles (r=0.61, 
p<0.001), years of amenorrhea (r=-0.53, p<0.01) and years of oligomenorrhea (r=-0.44, 
p=0.01). The only menstrual variable that was significantly correlated with lumbar spine 
BMD for those subjects with a history of oligo/amenorrhea (n=l4) was years ofregular 
menstrual cycles (r=0.59; p<0.05). This suggests once again that the number of periods 
experienced rather than the number of periods missed is important in the determination of 
bone mineral density. However, although lumbar spine BMD of the runners who had 
resumed regular menses (CR) was somewhat higher than the runners who were currently 
oligo/amenorrheic (COA), this was not significant and both groups had a significantly lower 
lumbar spine BMD than the regularly menstruating runners (R). These data suggest that, 
although resumption of menses is beneficial to the bone mineral density of the lumbar spine, 
any history of menstrual irregularity is still harmful to bone health. 
Once again we found no difference in lumbar spine BMD between those subjects who had 
current or prior amenorrhea (HOA) and those who had current or prior oligomenorrhea but no 
history of amenorrhea. However, both groups were significantly lower than those subjects 
who had never experienced menstrual irregularities, suggesting that a history of 
oligomenorrhea may be as detrimental to the lumbar spine as a history of amenorrhea, and 
that any history of menstrual irregularity will place one at risk of reduced bone mineral 
density. 
1v CONCLUSIONS OF STUDY 1 
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The findings of the addendum support the significant findings of study 1 and show that in 
mature women distance runners low lumbar spine BMD is related to a history of 
oligo/amenorrhea and that a significant history of oligomenorrhea should not be considered to 
be less harmful to lumbar spine BMD than a history of amenorrhea. Menstrual regularity and 
the number of menstrual periods experienced may be more important than the number of 
periods missed in the determination ofBMD. However, even those women who have 
resumed regular menses still have a distinctly lower lumbar spine BMD compared to women 
who have always had regular menstrual periods. 
CHAPTER 3 
Long term accretion of bone mineral density in premenopausal women with prior 
menstrual irregularity 
STUDY2 
1. INTRODUCTION 
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We concluded from the previous study that a history of oligo/amenorrhea, regardless of 
the resumption of regular menstrual cycles, is associated with low lumbar spine BMD. 
Indeed, no studies have shown full restoration of lumbar spine BMD in previously 
oligo/amenorrheic subjects relative to controls. The large increases in lumbar spine BMD 
(6.3 % in 15.5 months; Drinkwater et al., 1986); (14.4 % over 2 years; Jonnavithula et al., 
1993) have been shown in young groups of subjects (27.9 ± 2.0 yr; Drinkwater et al., 
1986); (20.4 ± 5. 7 yr; Jonnavithula et al., 1993). Therefore, the aim for study 2 is to 
determine whether (i) a history of oligo/amenorrhea, in relatively older women who have 
regained and maintained regular menses for a relatively long period of time since their 
episode/s of menstrual irregularity, will have a less pronounced influence on lumbar spine 
BMD, or (ii) the previously significant influence of oligo/amenorrhea on lumbar spine 
BMD would no longer exist when compared with women who have never had irregular 
menstrual periods. 
Although it is accepted that large amounts of bone mass are attained during puberty 
(Bonjour et al., 1991), with an additional smaller gain in BMD into the late 20's (Recker 
et al., 1992a), in exercising women bone acquisition may continue for longer. There is 
controversy regarding the age at which bone loss begins (Buchanan et al., 1988; Lindsay 
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et al., 1993; Szejnfeld et al., 1993). There is evidence to show that sedentary women start 
to lose bone prior to menopause (Buchanan et al., 1988; Bonjour et al., 1991). Limited 
cross-sectional data seem to show that this may not apply to exercising women (Brewer et 
al., 1983), however no longitudinal data have confirmed this. There is also evidence to 
suggest that young women who have had amenorrhea but regain regular menses have a 
partial restitution of BMD (Drinkwater, 1989). However, it is not known whether 
exercising women with a history of menstrual irregularity will be able to regain BMD 
throughout their premenopausal years and eventually obtain a peak bone mass similar to 
their regularly menstruating peers. 
ii HYPOTHESES OF STUDY 2 
We hypothesise 
i) that in more mature women distance runners with a history of menstrual irregularity 
( even if regular menstrual cycles have been regained for a longer period of time) there 
will still be a significantly lower lumbar spine BMD than in women who have had no 
history of menstrual irregularity, 
ii) that the sedentary control group will have a lower lumbar spine BMD than the 
regularly menstruating runners, but a higher lumbar spine BMD than the runners with 
current menstrual irregularity and/or a history of oligo/amenorrhea, and 
iii) that bone mass continues to be acquired during the fourth decade in exercising 
women., but that sedentary women may begin to lose bone mass during this time. 
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11 MATERIALS AND METHODS 
Subjects 
We attempted to contact all forty women who had been randomly selected for the first 
study three years previously. Some of the reasons for not participating in the second 
study included leaving the country (n=5), current pregnancy (n=2), and no longer taking 
part in regular running (n=5). We were unable to contact a further five women and four 
women were not willing to participate in another study. We therefore also contacted 15 
women who had participated in a similar study five years previously, and from this 
sample 3 subjects were recruited and the rest of the questionnaires were returned to the 
sender due to change of address. A final sample of 22 runners agreed to participate in the 
study. Regular competitive running was not a requirement, but all the subjects were 
required to be running at least 3-4 times/week. Most subjects were also participating in 
some other form of exercise. 
A control group of sedentary women were recruited by obtaining names and addresses of 
women who had undergone a bone density scan at Groote Schuur Hospital in the previous 
3-5 years. The database contained only sixty women who were of similar age and had 
served as healthy controls for previous research. These women were all contacted, 
however exclusion criteria for the current study included: participating in regular exercise 
at present or in the last five years, presently menopausal or post-menopausal, and the 
experience of current or previous menstrual irregularities. A final sample of only 8 
sedentary control (SC) women qualified and agreed to participate in the study. None of 
the sedentary control group had participated in formal exercise during adulthood. 
Subject details including age, height, highest adult body weight, lowest adult body 
weight, training (where applicable), menstrual history and the use of oral contraceptive 
medications, were obtained from an initial questionnaire (see Appendix 1 ). Body Mass 
Index (BMI) and change in BMI (DBMI) were calculated as follows: 
BMI = mass*height-2 (kg.m-2) 
DBMI = highest adult BMI - lowest adult BMI (kg.m-2) 
Protocol 
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An osteodensitometry scan was performed in the Department of Nuclear Medicine, 
Groote Schuur Hospital using a Hologic QDR-1000 (version 4.20) dual-energy x-ray 
bone densitometer (Hologic Inc., Waltham, MA). The machine is calibrated daily to 
assure proper operation of the system, by the scanning of an anthropomorphic spine 
phantom. There was a percentage coefficient of variation (CV) over the period during 
which the first scans were done of 0.44% (61 scans) and a CV of 0.36% (169 scans) 
during the period when the second scans were done. The difference in the mean value 
obtained for the phantom spine from time period 1 to time period 2 was 0.0006 g.cm-2. 
An in-house study done at the Department of Nuclear Medicine, Groote Schuur Hospital, 
investigated the in-vivo precision of an Hologic QDR-1000 Bone Densitometer and the 
accuracy of the operator. Test-retest reproducibility was 0.99 for 20 women. Rate of 
change was calculated using the computers COMP ARE function. Scans were made of 
the lumbar spine and the left proximal femur. Average bone mineral densities (g.cm-2) 
were determined for lumbar vertebrae 1 through 4 and the total proximal femur, Ward's 
triangle, femoral neck, greater trochanter, and the intertrochanteric space. For 10 of the 
29 scans of the proximal femur, an accurate value of the Ward's triangle could not be 
found, so this particular area was excluded from further investigation. 
Values for bone mineral content (BMC, g) and projected area (Ap, cm2) of the lumbar 
spine obtained from the bone scan were used to calculate bone mineral apparent density 
(BMAD, g.cm-3) of L2-L4 (Carter et al., 1992). This is a more accurate method of 
comparing the density of bones of different sizes than the more traditional method of 
measuring BMD based on area only. BMAD = BMC*(Ap-1.5). 
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Each subject was then interviewed and required to complete a detailed questionnaire in 
order to obtain more detailed information about their current menstrual status and 
previous menstrual history (see Appendix 2). Information included age at menarche, the 
estimated number of periods per year since menarche, the use of oral contraceptives, 
fertility drugs or hormone injections, as well as whether they had undergone procedures 
such as a hysterectomy or ovariectomy. Information on reproductive history, such as 
parity and total months of breastfeeding, was also obtained. This information was used to 
calculate the following: 
(i) Menstrual History Index (modified from Grimston et al., 1990). This was calculated 
to determine the estimated number of periods per year since age 13. 
Menstrual History Index= (l l.5*R + 7*0 + 1.5* A)/(C-13) where: 
R = number of years of regular menstrual cycles ( defined as 10-13 menstrual periods 
per year and assuming an average of 11.5 periods.yr-I); 
0 = number of years of oligomenorrhea ( defined as 4-9 menstrual periods per year and 
assuming an average of 7 periods.yr-I); 
A = number of years of amenorrhea ( defined as 0-3 menstrual periods per year and 
assuming an average of 1.5 periods.yr-I); 
C = current age. 
(ii) The Menstrual History Index was then divided into the estimated number of periods 
per year for the following three time periods: 
13-20 years of age 
21-3 0 years of age ( or 21 to present age) 
31-40 years of age ( or 31 to present age) 
41 to present age 
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Information about previous dairy product intake was obtained from the questionnaire and 
was reported as the estimated number of portions consumed per week during junior 
school, high school, on leaving school and over the past year. One portion was 
equivalent to 1 cup of milk, 175 ml of yoghurt, a rounded scoop of ice-cream, a 250 g tub 
of cottage cheese, and a cheese meal or sandwich. 
All subjects were also required to complete a 3 day dietary record in order to determine 
total energy intake (MJ) per day, as well as daily intake of calcium (mg), phosphorus 
(mg), protein (g), fat (g), carbohydrate (g), and fibre (g). Dietary intake was recorded on 
2 week days and 1 weekend day and analysed using the food quantities tables of the 
National Research Institute for Nutritional Diseases (Parow, South African Medical 
Research Council Publications Unit, 1986) and a computerised dietary analysis 
programme (Foodfinder, Medical Research Council, Parow, South Africa). 
Daily energy expenditure (MJ.d-1) was estimated from a seven day activity diary. 
Subjects were required to divide the day into number of hours spent sleeping (Level 1), 
somewhat active, including activities such as leisurely walking, standing, driving and 
reading (Level 1.5), active, including activities such as brisk walking, sweeping and 
mopping (Level 4), very active, including activities such as brisk uphill walking and 
climbing stairs (Level 6), and extremely active, including running (Level 9). This 
method was modified from the interview method of estimating daily energy expenditure 
used by Blair et al. (1985). 
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Each subject then visited the laboratory where body composition was measured and 
calculated according to the method of Durnin and Wormesley (1974). Skinfold 
measurements were taken by the same investigator, in all cases, on the right side at the 
triceps, biceps, subscapular, and suprailiac sites. Fat mass,% body fat, and fat-free mass 
were calculated. Somatotype was assessed using the Heath-Carter method (1967). 
Venous blood samples were then drawn between 9.30 and 9.45 am from subjects who had 
not exercised that morning, in order to determine osteocalcin concentration by means of a 
specific radioimrnunoassay performed on serum samples (OSTK-PR Kit, CIS bio 
international, ORIS Group, France). The principle is based on competition between 
osteocalcin radiolabelled with iodine-125 and osteocalcin contained in the standards or 
samples to be assayed for a given limited number of anti-osteocalcin antibody sites. At 
the end of the incubation period, the amount of radio labelled osteocalcin bound to the 
antibody is inversely proportional to the amount of non-radio labelled osteocalcin 
originally present in the assay. 
Twenty-four hour urine samples were obtained from all the subjects and an aliquot was 
immediately frozen and stored in the dark. The concentration of free deoxypyridinoline 
cross-links (DPD), corrected for urinary concentration of creatinine, was determined by 
the Pyrilinks-D assay (Metra Biosystems, Inc., USA). The accuracy of this method has 
been confirmed due to a strong correlation of Pyrilinks-D values with total DPD 
measured by HPLC (r=0.93), and with collagen crosslinks measured by Pyrilinks™ 
(Metra Biosystems, Inc.)(r=0.96). 
Data analysis 
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One-way ANOV A's were performed to compare data from runners who had always had 
regular menstrual cycles (R, n=I2), runners with current or previous menstrual 
irregularity (OA, n=9), and sedentary controls who had always had regular menstrual 
cycles (SC, n=8). One-way ANOV A's were also performed to compare changes in mass, 
MHI and the different bone parameters in the three groups since the last study. 
ANCOVA's co-varying for age and age at menarche, together and separately, were 
performed when comparing years of regular menstruation and total number of periods of 
the three groups. ANCOVA's co-varying for age and body mass, together and separately, 
were performed when comparing the bone parameters of the three groups. ANCOV A's 
co-varying for age, current body mass, and change in body mass, together and separately, 
were performed when comparing the annualised changes in the bone parameters of the 
three groups. Kruskal-Wallis tests were performed to compare the BMD data of three 
groups of runners after dividing the subjects into those runners who had always had 
regular menstrual function (R), those who had oligo/amenorrhea in the past but who had 
now resumed regular menstrual cycles (CR, n=7), and those runners who were currently 
oligo/amenorrheic (COA, n=2). Kruskal-Wallis tests were also performed to compare the 
BMD data of three groups of runners after dividing the runners into those women who 
had always had regular menstrual cycles (R), those who had a history of oligomenorrhea 
with no history of amenorrhea (HO, n=5), and those runners who had a history of either 
amenorrhea or both amenorrhea and oligomenorrhea (HOA, n=4). Pearson-product 
moment correlation coefficients were calculated to determine which variables were 
significantly correlated with BMD, and change in BMD, for the whole sample of women, 
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as well as between selected variables to determine if they had an indirect effect on BMD. 
Pearson-product moment correlation coefficients were also calculated to determine which 
menstrual variables were significantly correlated with lumbar spine BMD in the sub-
group of runners with current and/or previous menstrual irregularity (OA). Several 
physical characteristics (mass, BMI, DBMI, % body fat) which showed the largest simple 
correlations with BMD were entered into a stepwise selection in order to determine the 
most significant predictor/s of lumbar spine BMD from this category. A similar 
procedure was followed for the menstrual history variables in which total estimated 
periods per year from 21-30 years of age, total number of years of oligomenorrhea, total 
number of years of amenorrhea, and MHI were entered into the stepwise selection. 
Lumbar spine BMAD was calculated for all the women and ANOVA's were performed to 
compare the data of the three groups. Pearson-product moment correlation coefficients 
were calculated between lumbar spine BMAD and several physical characteristic 
variables ( current body mass, height, BMI and DBMI), and the same variables were 
entered into a stepwise variable selection in order to determine the most significant 
predictor/s of lumbar spine BMAD. 
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m RESULTS 
Comparison of groups 
Physical characteristics (Table 3 .1) 
Twelve runners (R) and eight sedentary controls (SC) had always been regular ( 10-13 
periods.yr-I), and nine runners had a history of oligo/amenorrhea, (OA, 0-9 periods.yr-I). 
Subject no. 12 was an outlier and was excluded from all statistical analyses due to a 
change in lumbar spine BMD larger than 2 standard deviations above that for the group, 
as well as a DBMI value above 2 standard deviations above that of the group (see Table 
3.1). Subjects ranged in age from 29 to 46 yr of age. The oligo/amenorrheic (OA) 
runners were significantly younger than the sedentary control group (OA: 35.9 ± 4.4 vs 
SC: 41.6 ± 3.1 yr; p=0.01) but did not differ in age from the regular group (R: 39.0 ± 3.8 
yr). Body mass of the sedentary controls was significantly higher than the regularly 
menstruating runners (SC: 63.3 ± 8.6 vs R: 56.3 ± 7.9 kg; p<0.05) and the 
oligo/amenorrheic runners (SC: 63.3 ± 8.6 vs OA: 54.4 ± 3.8 kg; p<0.05). The BMI of 
the sedentary controls was significantly higher than the regular group (SC: 23.9 ± 3.4 vs 
R: 20.4 ± 1.8 kg.m-2; p<0.05) and the oligo/amenorrheic group (SC: 23.9 ± 3.4 vs OA: 
20.2 ± 1.5 kg.m-2; p<0.05). The DBMI (highest - lowest BMI) was not significantly 
different among the groups. The anthropometric measurement of endomorphy was 
significantly higher in the sedentary controls than the other two groups. The 
mesomorphic component was similar between the three groups. The sedentary control 
group had a significantly lower measure of ectomorphy than the other two groups. 
Calculated % body fat was significantly lower in the oligo/amenorrheic group than the 
regularly menstruating runners and the sedentary controls (OA: 25.0 ± 3.8 vs R: 28.1 ± 
3.6; or SC: 34.2 ± 2.8 %; p<0.001). The sedentary control group had a significantly 
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higher fat mass than the other two groups (SC: 21.8 ± 4.8 vs R: 15.8 ± 3.2; or OA: 13.7 ± 
2.7 kg; p<0.001). There was no difference in fat free mass (FFM) among the three 
groups. 
TABLE 3.1 Physical characteristics of ultramarathon runners who had current and/or prior 
oligo/amenorrhea, and ultramarathon runners and sedentary controls who had always had regular 
menstrual cycles. 
Current/prior Always Regular Sedentary Significance 
oligo/amenorrhea controls 
(OA, n=9) (R, n=12) (SC, n=8) 
Age (yr) 35.9 ± 4.4 39.0 ± 3.8 41.6±3.1 p<0.01 OA vs SC 
Mass (kg) 54.4 ± 3.8 56.3 ± 7.9 63.3 ± 8.6 p<0.05 OA vs SC 
p<0.05 R vs SC 
Height (cm) 164.3 ± 4.1 165.8 ± 7.3 162.9 ± 5.9 NS 
BMI (kg.m-2) 20.2 ± 1.5 20.4±1.8 23.9 ± 3.4 p<0.05 OA vs SC 
p<0.05 R vs SC 
DBMI (kg.m-2) 5.2 ± 2.2 3.0 ± 1.7 4.9 ± 2.6 NS 
Endomorphy 3.5 ± l.l 4.0 ± 0.9 6.3 ± 1.3 p<0.001 OA VS SC 
p<0.001 R vs SC 
Mesomorphy 3.8 ± 1.3 3.7 ± 0.8 4.7 ± 1.0 NS 
Ectomorphy 3.2 ± 0.9 3.2 ± 0.9 1.7 ± 1.2 p<O.O 1 OA vs SC 
p<0.01 RVS SC 
Body fat(%) 25.0 ± 3.8 28.1 ± 3.6 34.2 ± 2.8 p<0.001 OA vs R vs SC 
Lean body mass 40.8 ± 2.5 40.3 ± 5.6 41.5±4.1 NS 
(kg) 
Data are presented as means± SD. Statistical analysis: one-way ANOV A. 
Current menstrual status and history (Table 3.2) 
Of the 9 subjects with a history of oligo/amenorrhea, 7 had regained regular menses, 
while one woman was currently amenorrheic and another was currently oligomenorrheic. 
The remaining seven OA subjects had been consecutively regular for between 1 and 25 
years (11.7 ± 7.9 yr). There was no difference in age at menarche among the three groups 
(see Table 3.2). Years ofregular menstruation, after co-varying for age, was significantly 
different among all the groups (OA: 15.2 ± 7.9 vs R: 25.9 ± 4.4 vs SC: 29.4 ± 2.8 yrs; 
p<0.001), however after co-varying for age at menarche as well as age, there was no 
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longer a significant difference in years of regular menstruation between the regularly 
menstruating runners and the sedentary controls. The oligo/amenorrheic group had a 
total of 4.9 ± 4.2 years of oligomenorrhea, and the mean years of amenorrhea was 2.4 ± 
3.6 years. The oligo/amenorrheic group had a total of217.7 ± 78.8 periods since 
menarche, which was significantly (p<0.01) less than the regularly menstruating runners 
(298.0 ± 50.6) after co-varying for age. Both groups had significantly (p<O.O 1) less total 
periods than the sedentary control group (337.8 ± 31.9) after co-varying for age. After 
co-varying for age and age at menarche, the three groups were still significantly different 
(p<0.01). The MHI was significantly lower in OA than Rand SC (OA: 9.1 ± 2.0 vs R: 
11.3 ± 0.5; or SC: 11.8 ± 0.4; p<0.001). The MHI of OA subjects was significantly 
different from the other two groups between age 13 and 20 (p<0.01), age 21 and 30 
(p=0.001), and between age 31 and 40 (p<0.01). Only 2 women from the 
oligo/amenorrheic group were over the age of 40, and both of them were currently 
regular. 
Reproductive status (Table 3.2) 
Parity (number of pregnancies) and months of breastfeeding were similar in all three 
groups (OA: 1.0 ± 1.7 vs R: 1.3 ± 1.2 vs SC: 1.5 ± 1.1 children) and (OA: 7.2 ± 11.6 vs 
R: 6.0 ± 12.6 vs C: 9.3 ± 9.2 months). Four runners were currently taking oral 
contraceptives, 2 in the oligo/amenorrheic group, and 2 in the group that had always had 
regular menstrual cycles. None of the women in the sedentary control group were 
currently taking an oral contraceptive. There was no difference among the groups for 
total years on oral contraception (OA: 5.9 ± 5.4 vs R: 6.0 ± 4.4 vs SC: 8.5 ± 4.4 yr). One 
sedentary control subject had had a hysterectomy 2 years previously, but not an 
ovariectomy. She still experienced the symptoms associated with ovulation and the 
premenstrual period every month. Five women had undergone tubuligation. 
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TABLE 3.2 Variables related to the past and present menstrual and reproductive status of 
ultramarathon runners who had current and/or prior oligo/amenorrhea, and ultramarathon runners 
and sedentary controls who had always had regular menstrual cycles. 
Current/prior Always Sedentary 
oligo/amenorrhea Regular controls 
(OA, n=9) (R, n=l2) (SC, n=8) 
Menarcheal age (yr) 13.3 ± 1.7 13.3 ± 1.2 12.4 ± I.I 
Menstrual History Index 9.1 ± 2.0 11.3 ± 0.5 11.8 ± 0.4 
(periods. yr I since 13 yr) 
Estimated no. Periods.yr- l: 
13-20 yr of age 8.4±3.6 10.9±1.9 12.5 ± 1.7 
21-30 yr of age 9.3 ± 3.1 11.5±0 11.5±0 
3 1-40 yr of age 9.6 ± 2.4 (n=8) 11.5±0 11.5±0 
41-46 yr of age 11.5 ± 0 (n=2) 11.5 ± 0 (n=5) 11.5 ± 0 
(n=4) 
Total no. Periods# 217.7±78.8 298.0 ± 51.0 337.8 ± 31.9 
Years regular # 15.2 ± 7.9 25.9 ± 4.4 29.4 ± 2.8 
Years amenorrheic 2.4 ± 3.6 0 0 
Years oligomenorrheic 4.9 ± 4.2 0 0 
Months of breastfeeding 7.2 ± 11.6 6.0 ± 12.6 9.3 ± 9.2 
Number of children 1 ± 1.7 1.3 ± 1.2 1.5±1.1 
Total years on oral 5.9 ± 5.4 6 ±4.4 8.5 ± 4.4 
contraception 
Data are presented as means± SD. Statistical analysis: one-way ANOV A. 
# One-way ANCOV A, co-varying for age 
Exercise status (Table 3.3) 
Significance 
NS 
p<0.001 OA vs R 
p<0.001 OA vs SC 
p<0.01 OA VS R 
p<0.01 OA vs SC 
p=0.01 OA vs R 
p=0.01 OA vs SC 
p<0.01 OA vs R 
p<0.01 OA vs SC 
NS 
p<O.O I OA vs R vs SC 
p<0.001 OA vs R vs 
SC 
p=0.01 OA vs R 
p=0.01 OA vs SC 
p<0.001 OA vs R 
p<0.001 OA VS SC 
NS 
NS 
NS 
Maximum weekly training distance (km.wk-1) during any competitive season (ie. not 
necessarily the year of the study) was significantly higher in the oligo/amenorrheic 
runners than the regularly menstruating runners (OA: 109 ± 37 vs R: 72 ± 25 km.wk-I; 
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p=O.O 1 ). More than 70% of the runners participated in other activities such as cycling, 
swimming and walking, but running was their primary exercise activity. There was no 
difference between the two groups of runners for total daily estimated energy expenditure 
(OA: 10.8 ± 1.9 vs R: 11.8 ± 2.6 MJ.d-1 ), and neither group was significantly different 
from the sedentary control group (SC: 11.1 ± 3.1 MJ.d-1 ). However, hours.wk-I at level 
9 ( extremely active) was significantly lower in the sedentary group than the two running 
groups (OA: 6.6 ± 2.5, R: 5.5 ± 3.4 vs SC: 0.3 ± 0.7 hours.wk-I; p=0.0001). There was 
no significant difference among the three groups at the other levels of activity. The two 
groups of runners did not have significantly different personal best race times for the Two 
Oceans 56 km-marathon (OA: 301.4 ± 46.1 vs R: 326.6 ± 20.5 min) or a standard half 
marathon (21.1 km) (OA: 93.6 ± 13.2 vs R: 99.4 ± 10.3 min), and years of running 
training (OA: 7.1 ± 3.9 vs R: 7.3 ± 3.0 yr). None of the subjects in the sedentary control 
group had taken part in any formal exercise program during adulthood. 
TABLE 3.3 Exercise histories and total estimated energy expenditure of ultramarathon runners who 
had current and/or prior oligo/amenorrhea, and ultramarathon runners and sedentary controls who 
had always had regular menstrual cycles. 
Current/prior Always Regular Sedentary Significance 
oligo/amenorrhea controls 
(OA, n=9) (R, n=l2) (SC, n=8) 
Energy expenditure(MJ.d-1) 10.8 ± 1.9 11.8 ± 2.6 11.1±3.1 NS 
Hrs.wk-1: level 1.5 79.0 ± 27.7 75.8 ± 19.2 89.1±16.8 NS 
level 4 20.4 ± 20.3 18.9±12.1 19.6±21.3 NS 
level 6 5.3 ± 5.9 8.1± 9.1 3.7 ± 4.4 NS 
level 9 6.6 ±2.5 5.5 ± 3.4 0.3 ±0.7 p<0.001 
OA VS SC 
R vs SC 
Maximum km.wk-1 108.9 ± 36.8 72.1 ± 25.2 0 p=0.01 OA vs R 
Personal best race time (min) 
56 km 301.4 ± 46.1 (n=8) 326.6 ± 20.5 (n=lO) 0 NS 
21.1 km 93.6 ± 13.2 (n=9) 99.4 ± 10.3 (n=l l) 0 NS 
Marathon training (yr) 7.1±3.9 7.3 ± 3.0 0 NS 
Data are presented as means± SD. Statistical analysis: one-way ANOV A. 
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Bone mineral density (Table 3.4) 
After co-varying for age and mass, lumbar spine BMD of the oligo/amenorrheic runners 
was significantly lower than the lumbar spine BMD of the regularly menstruating runners 
and the sedentary controls, who were not different (OA: 0.948 ± 0.070 vs R: 1.043 ± 
0.100; or SC: 1.094 ± 0.077 g.cm-2; p<0.05). There was a significant difference between 
OA and SC for BMAD (OA: 0.125 ± 0.009 vs SC: 0.146 ± 0.010 g.cm-\p<0.01) but 
neither were significantly different from R (0.135 ± 0.010 g.cm-3). BMAD of those 
women who had oligo/amenorrhea in the past but who had now resumed regular 
menstrual cycles (0.123 ± 0.008 g.cm-3) was significantly different from BMAD for the 
sedentary control group. The three groups did not differ for BMD of the proximal femur 
(total, neck, trochanter, and intertrochanter). 
TABLE 3.4 Bone parameters of ultra marathon runners who had current and/or prior 
oligo/amenorrhea, and ultramarathon runners and sedentary controls who had always had regular 
menstrual cycles. 
Current/prior Always Sedentary 
oligo/amenorrhea Regular controls 
(OA, n=9) (R, n=l2) (SC, n=8) 
Lumbar Spine BMD 0.948 ± 0.071 1.043±0.103 1.094 ± 0.077 
(g.cm-2) # 
Lumbar Spine BMAD 0.125 ± 0.010 0.135±0.010 0.146 ± 0.010 
(g.cm-3) 
Femur: 
Neck (g.cm-2) 0.837 ± 0.066 0.843 ± 0.106 0.773 ± 0.075 
Trochanter (g.cm-2) 0.669 ± 0.063 0.712 ± 0.127 0.683 ± 0.050 
Intertrochanter (g.cm-2) 1.065 ± 0.092 1.093 ± 0.179 1.039 ± 0.076 
Total hip (g.cm-2) 0.913 ± 0.069 0.934 ± 0.149 0.893 ± 0.057 
Data are presented as means± SD. Statistical analysis: one-way ANOV A. 
# One-way ANCOV A, co-varying for age and mass 
Significance 
p<0.05 OA vs R 
p<0.05 OA vs SC 
p<0.01 OA VS SC 
NS 
NS 
NS 
NS 
Dietary intake (Table 3.5) 
There were no significant differences among groups for current reported daily energy 
intake (OA: 6.6 ± 2.1 vs R: 7.7 ± 2.2 vs SC: 6.3 ± 1.2 MJ.d-1) and calcium intake (OA: 
772.6 ± 293.9 vs R: 936.4 ± 371.4 vs SC: 765.7 ± 159.6 mg.d-1) or for any other 
measured component of the diet. However subjects from all three groups exhibited 
extremely low levels of total energy intake and calcium intake. A total energy intake of 
less than 6.5 MJ.d-1 was present in 4 of the 9 subjects in the OA group, 5 of the 12 
subjects in the R group, and 5 of the 8 subjects in the SC group. Similarly, a calcium 
intake of less than the RDA of 800 mg.d-1 was present in 5 of the 9 subjects in the OA 
group, 5 of the 12 subjects in the R group, and 3 of the 8 subjects in the SC group. A 
calcium intake ofless than 500 mg.d-1 was present in 2 of the subjects in the OA group, 
2 of the subjects in the R group, and 1 of the subjects in the SC group. There was no 
difference in dairy product intake (portions of dairy.wk-I) among the three groups. 
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TABLE 3.5 Dietary intake and history of dairy product intake of ultramarathon runners who had 
current and/or prior oligo/amenorrhea, and ultramarathon runners and sedentary controls who had 
always had regular menstrual cycles. 
Current/prior Always Sedentary Significance 
oligo/amenorrhea Regular controls 
(OA, n=9) (R, n=l2) (SC, n=8) 
Total energy (MJ.d-1) 6.6 ± 2.1 7.7 ± 2.2 6.3 ± 1.2 NS 
Calcium (mg.d-1) 773 ± 294 936 ± 371 766 ± 160 NS 
Phosphorus (g.d-1) 1078 ± 256 1290 ± 378 1146±206 NS 
Protein (g.d-1) 60.4 ± 13.53 69.8 ± 17.0 66.4 ± 14.6 NS 
Fat (g.d-1) 54.5 ± 23.9 65.9 ± 27.2 55.5 ± 16.6 NS 
Carbohydrate (g.d-1) 188 ± 76 222 ± 57 174±41.2 NS 
Fibre (g.d-1) · 16±3.3 19.2 ± 5.5 17 ± 8 NS 
Portions of dairy products. wk- I 
Past year 15.6±6.4 13.8±5.0 17.8±10.5 NS 
On leaving school 15.3 ± 5.7 11.9 ± 5.8 12.9±6.l NS 
During high school 15.1±6.7 10.7 ± 5.4 11.6±7.5 NS 
During junior school 17.7 ± 10.6 12.9 ± 6.7 13.4 ± 8.7 NS 
Total portions/4 15.9 ± 6.4 12.3 ± 4.9 13.9±6.1 NS 
Data are presented as means± SD. Statistical analysis: one-way ANOV A. 
Biochemical markers (Table 3.6) 
Osteocalcin and DPD/Creatinine were similar in the three groups (OA: 8.3 ± 1.4 vs R: 8.4 
± 1.6 vs SC: 8.1 ± 2.9 ng.ml-1) and (OA: 3.9 ± 1.4 vs R: 3.5 ± 1.1 vs SC: 3.8 ± 2.0 nM 
Dpd.mM Crearl). Osteocalcin values generally vary between 2 and 12 ng.m1-l 
(Gundberg, 1990). Values obtained in this study ranged from 3.5 to 12.6 ng.m1-l. 
Preliminary Pyrilinks-D reference ranges established by Metra Biosystems for normal 
premenopausal females (n=55) over 25 years of age were 2.0-6.0 nM Dpd.mM Creat-1. 
The range of values in this study was 1.7-8.4 nM Dpd.mM Crear 1. 
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TABLE 3.6 Biochemical markers of bone turnover of ultramarathon runners who had current 
and/or prior oligo/amenorrhea, and ultramarathon runners and sedentary controls who had always 
had regular menstrual cycles. 
Current/prior Always Sedentary Significance 
oligo/amenorrhea Regular controls 
(OA, n=9) (R, n=l2) (SC, n=8) 
Osteocalcin (ng.mi-1) 8.3±1.4 8.4 ± 1.6 8.1 ± 2.9 NS 
Volume of urine (ml) per 1661.8 ± 948.4 1443.2 ± 730.8 1908.8 ± 855.6 NS 
24 hours 
DPD/Creatinine 3.9 ± 1.4 3.5 ± 1.1 3.8 ± 2.0 NS 
(nM Dpd.mM Creac 1) 
Data are presented as means± SD. Statistical analysis: one-way ANOV A. 
Analysis by correlation 
Lumbar Spine BMD for the whole sample of women correlated significantly with body 
mass (p<0.05, r=0.39), and BMI (p=0.01, r=0.46). Lumbar Spine BMD correlated 
significantly with the total number of years of oligomenorrhea (p<0.05, r=-0.38), the total 
number of years of amenorrhea (p=0.01, r=-0.45), and the overall MHI (p=0.01, 
r=0.45)(Figure 3 .1 ). Lumbar Spine BMD for the whole sample of women also correlated 
significantly with the estimated number of periods per year from 21-30 years of age 
(p=0.01, r=0.46), but not for ages 13-20 yrs or 31-39 years. 
Lumbar spine BMD for the sub-group of runners with current and/or prior 
oligo/amenorrhea (n=9) was not significantly correlated with any of the menstrual 
variables. Lumbar spine BMD for groups OA and R together, correlated significantly 
with total number of years of amenorrhea (p<0.05, r=-0.44) and estimated number of 
periods per year from 21-30 years (p<0.05, r=0.44). Neither proximal femur or neck of 
the femur were significantly correlated with any of the menstrual variables for the sub-
group of runners with current and/or prior oligo/amenorrhea, or for the whole sample of 
runners. 
92 
As BMD was significantly correlated with lumbar spine BMD, we determined which 
factors may be correlated with BMD and thus have an indirect influence on lumbar spine 
BMD. BMI was positively correlated with total daily estimated energy expenditure 
(p<0.001, r=0.73), as well as% body fat (p<0.001, r=0.73), and DBMI (p<0.001, r=0.60). 
Although there was not a significant correlation between months of breastfeeding in the 
women who had had children (n=l6) and lumbar spine BMD, an r-value of -0.40 was 
obtained. No dietary or training variables correlated with lumbar spine BMD for the 
whole sample of women. No other bone parameters, including the total proximal femur, 
neck of the femur, greater trochanter, and the intertrochanteric space, correlated with any 
body composition, menstrual, training or dietary variables. BMAD for the whole sample 
of women correlated significantly with BMI (p<0.05, r=0.41), but not with any other 
physical characteristics. 
Change in lumbar spine BMD since the last study correlated significantly with change in 
mass since the last study (p=0.05, r=0.36)(Figure 3.2), but was not significantly 
correlated with change in MHI, estimated portions of dairy products per week over the 
past year, current calcium intake, or total energy intake. 
Stepwise variable selection 
Two physical characteristic variables emerged from stepwise variable selection as 
significant predictors of lumbar spine BMD (r2=0.36, p=O.O 1 ). The prediction equation 
for BMD of the lumbar spine using physical characteristic variables was: 
BMD1umbar spine= (BMI x 0.03) + (DBMI x -0.02) + 0.52 (r2=0.36) 
No physical characteristic variables emerged as significant predictors of the total 
proximal femur, the femoral neck, the greater trochanter, or the intertrochanteric space. 
93 
One menstrual variable emerged as the most significant predictor of lumbar spine BMD 
(r2=0.20, p<0.05). The prediction equation for BMD of the lumbar spine using menstrual 
variables was: 
BMDlumbar spine= (MHI x 0.03) + 0.72 (r2=0.20) 
The two most significant predictors of BMAD were BMI and DBMI (r2=0.30, p<0.01). 
The formula which best predicted BMAD was: 
BMAD = (BMI x 0.004) + (DBMI x -0.003) + 0.07 (r2=0.30) 
Total number of years of amenorrhea emerged as the most significant predictor of lumbar 
spine BMD for the groups OA and R together (r2=0.20, p<0.05). The formula which best 
predicted BMD of the lumbar spine in the sample of runners only was: 
BMD1umbar spine= (Total years of amenorrhea x -0.02) + 1.02 (r2=0.20) 
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Changes since previous study (Table 3.7) 
There was a significantly longer period of time between the baseline and follow-up bone 
density scans of the sedentary control group than the other two groups, although the range 
for all three groups was similar: 3-5.4 years for the OA group, 3-5.5 years for the R group 
and 3.7-5.7 years for the SC group. OA runners lost on average 2.5 kg of body mass 
while the SC group gained an average of 3.6 kg of body mass, however the variation 
within the two groups was large and neither were significantly different from the R 
group. Change in MHI was significantly greater in the oligo/amenorrheic runners than 
the other two regularly menstruating groups, Rand SC (OA: 0.74 ± 0.9 vs R: 0 ± 0.04; 
SC: -0.13 ± 0.26; p<0.01). There was no significant difference in% change per year of 
the bone parameters between the three groups, with or without co-varying for age, current 
body mass and change in mass. Although the bone parameters tended to increase in the 
OA group and decrease in the SC group, these differences were not significant (see 
dashed line, Fig 3.3) It is also apparent from Fig 3.3 that for almost all subjects the 
absolute change in lumbar spine BMD per year was small and essentially insignificant. 
Only one subject in the whole sample of women showed a> 1 % decrease in BMD of the 
lumbar spine between the baseline and follow-up scans, however three subjects showed 
an increase of> 1 % in BMD of the lumbar spine. The greatest range of% change in 
BMD was seen in the trochanter. 
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TABLE 3. 7 Changes in body mass, MHI and bone mineral densities since the previous study in 
ultramarathon runners who had current and/or prior oligo/amenorrhea, and ultramarathon runners 
and sedentary controls who had always had regular menstrual cycles. 
Current/prior Always Sedentary Significance 
oligo/amenorrhea Regular controls 
(OA, n=9) (R, n=l2) (SC, n=8) 
Change in age (yrs) 3.7 ± 0.9 3.6 ± 0.8 4.7 ± 0.7 p<0.05 OA vs SC 
p<0.05 R vs SC 
Range (3 to 5.4) (3 to 5.5) (3.7 to 5.7) 
Change in mass (kg) * -2.53 ± 4.10 -0.61 ± 2.51 3.63 ± 7.22 p<0.05 OA VS SC 
Range (-12.5 to + 1.0) (-5to+3) (-6.5 to +15.0) 
Change in MHI * 0.74 ± 0.9 0 ± 0.04 -0.13 ± 0.26 p<0.01 OA vs R 
p<0.01 OA vs SC 
Range (-0.34 to +2.5) (-0.1 to +0.1) (-0. 75 to +0.03) 
Change in lumbar spine(%)# 0.10 ± 0.68 -0.17 ± 0.65 -0.11 ± 0.64 NS 
Range (-0.81 to + 1.08) (-l.04to+l.31) (-0.83 to +l.04) 
Change in neck(%)# 0.30 ± 1.34 -0.25 ± 0.85 -0.35 ± 0.71 NS 
Range (-1.67 to +2.09) (-1.61 to +0.93) (-1.05 to +1.07) 
Change in trochanter (%) # 0.28 ± 1.29 0.08 ± 0.78 -0.52 ± 1.24 NS 
Range (-0.99 to +2.83) (-1.07 to +l.14) (-3.09 to +0.87) 
Change in intertrochanter (%) # 0.24 ± 1.21 0.52 ± 0.69 -0.18 ± 1.2 NS 
Range (-1.31 to + 1.86) (-0.42 to + 1.69) (-1.97 to +2.09) 
Change in Total Hip (%) # 0.31±1.01 0.36 ± 0.58 -0.28 ± 0.90 NS 
Range (-0.98 to +l.81) (-0.39 to +1.23) (-1.58 to +1.39) 
* Absolute change (post test - pre test) 
# Annualised change (post test- pre test)/ (no.of years since pre test) 
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1v DISCUSSION 
This study in mature premenopausal women shows that despite an average of 9.0 ± 8.7 years 
of consecutively regular menses, women with a history of menstrual irregularity have reduced 
lumbar spine bone mineral density (BMD) relative to that of their athletic peers who had 
always had regular menstrual periods and sedentary controls who had also always 
menstruated regularly. Therefore, the main finding of this study is that lack of regular 
exercise is less detrimental to lumbar spine BMD in women in their fourth and fifth decades 
(mean age 38.8 ± 4.3 yr) than a history of menstrual irregularities associated with marathon 
running. In addition, this study found that lumbar spine BMD is relatively stable in women of 
this age. 
Although the sample of subjects may not be entirely representative of the general population, 
this study is not supposed to be a record of the prevalence of osteoporosis among runners and 
sedentary controls, but rather to determine the effect of a previous history of menstrual 
irregularity on BMD in runners. Although it may have only been those runners and controls 
that were concerned about their bone health who responded to the letter, we are still able to 
look at the relationships between the different variables within the groups. 
(a) Cross-sectional data 
It is well known that low lumbar spine BMD can be associated with menstrual irregularity in 
athletes (Cann et al., 1984; Drinkwater et al., 1984; Lindberg et al., 1984; Marcus et al., 1985; 
Nelson et al., 1986; Cook et al., 1987; Drinkwater et al., 1990; Warren et al., 1991; Myburgh 
et al., 1993; Jonnavithula et al., 1993; Rutherford et al., 1993; Micklesfield et al., 1995). 
Many studies comparing BMD of groups of athletes have only considered the current 
menstrual status of the athletes when measuring bone mineral density (Cook et al., 1987; 
Warren et al., 1991). However, our data supports findings from other studies (Lloyd et al., 
1988; Drinkwater et al., 1990; Grimston et al., 1990; Myburgh et al., 1993) that show that 
menstrual history is more important than current menstrual status for the prediction of low 
bone mass. We also show that there is a graded relationship, with the lowest BMD seen in 
those subjects with the greatest cumulative history of menstrual irregularity. 
The present study also confirms the data of Drinkwater et al. ( 1990) and Lindberg et al. 
100 
( 1987) who showed that even if previously irregular women athletes regained regular menses, 
lumbar spine BMD remained significantly lower than in women who had always had regular 
menses. There was still a significant difference in lumbar spine BMD between the regularly 
menstruating runners and controls, and the runners with a history of oligo/amenorrhea 
(p<0.05), despite only two women in the oligo/amenorrheic group still experiencing irregular 
menstrual periods. Even with the exclusion of these two currently irregular subjects, lumbar 
spine BMD was still significantly higher in the regularly menstruating group, as well as the 
sedentary control group, compared to those runners who were currently regular but had a 
history of oligo/amenorrhea. Contrary to the previous two studies in which subjects were re-
tested after only 15 months, subjects in this study were re-tested after 3-6 years, but those who 
had regained regular menses, had had consecutively regular periods for 11.7 ± 7.9 years 
(range 1-25 yr) prior to the second scan. Therefore, our study adds to existing data, by 
suggesting that even though the resumption of regular menses has a positive effect on bone 
status, women who have a history of menstrual irregularity will still be at greater risk of 
reduced bone density than their regularly menstruating peers for many years. 
The MHI is influenced by quite a few variables namely age at menarche, number of years of 
regular menstruation, oligomenorrhea and amenorrhea. In study 1 (Micklesfield et al., 1995) 
two of these variables correlated with lumbar spine BMD in the subgroup of subjects with a 
history of oligo/amenorrhea (years of regular menstruation and years of oligomenorrhea). 
With the addition of four more subjects to the sub-group of runners with current and/or prior 
oligo/amenorrhea, only years of regular menstruation was significantly related to lumbar spine 
BMD (addendum to study 1), while no relationship was found between lumbar spine BMD 
and the other two menstrual variables. However, the variable which was the most significant 
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predictor of lumbar spine BMD in the regularly and irregularly menstruating running groups 
was the total number of years of amenorrhea. With the inclusion of the sedentary controls all 
of whom were, and always had been, menstruating regularly, total number of years of 
oligomenorrhea was significantly related to lumbar spine BMD (r=-0.38). But MHI, a 
measure of the average number of periods per year from 13 to current age, emerged as the 
most significant predictor of BMD for all subjects. Despite these inconsistencies, both studies 
seem to suggest that a history of oligomenorrhea should be considered as a significant 
contributor to the MHI and to low lumbar spine BMD. 
Our data also suggest that the age at which this menstrual irregularity occurred may also be 
important in the determination of peak bone mass. Findings of a study by Lloyd et al. (1988) 
concluded that regular menstruation and a normal age at menarche (implying adequate levels 
of circulating estrogen during adolescence) play a fundamental role in determining bone 
density in young women. Although the number of periods per year for the ages spanning 13-
20 years, 21-30 years and 31-40 years were all significantly lower in the irregularly 
menstruating group in our study, only the age range from 21-30 years was significantly 
correlated with lumbar spine BMD for the whole sample of women, including the sedentary 
controls, thus conflicting with the findings of Lloyd et al. (1988). However, their subjects 
averaged 19.0 ± 0.6 years of age and therefore the relative influence of the second vs the third 
decade on lumbar spine BMD could not be determined. We suggest that (i) a significant 
amount of adult bone mass is still gained after adolescence, and (ii) that bone mass is lost 
more easily after than during adolescence. These issues will be discussed in more detail in 
section (b ). 
The significant correlation between lumbar spine BMD and body mass supports the concept 
that mechanical loading may be beneficial to the maintenance of bone density (Aloia et al., 
1988). However, this association may be indirect as it has been suggested that there may be an 
association between lo,:v body weight and menstrual dysfunction (Lindberg et al., 1987). In 
comparison to controls who did not exercise regularly, the lumbar spine BMD of 
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oligo/amenorrheic athletes was still compromised, suggesting that regular exercise may not be 
sufficient to protect trabecular bone from the impact of hormonal imbalances that result from 
menstrual irregularities. These data also suggest that mechanical loading during daily tasks 
may be sufficient to load the spine of sedentary subjects. 
Cortical bone mass did not appear to be affected by the history of menstrual irregularity. 
Although this has been a common finding of many studies (Cann et al., 1984; Drinkwater et 
al., 1984, Marcus et al., 1985; Nelson et al., 1986; Rutherford, 1993), all of these studies have 
used the mid-radius as their reference for cortical bone. A study by Myburgh et al. (1993), 
which also found no difference at the mid-radius between amenorrheic and eumenorrheic 
athletes, did find that BMD of the proximal femur and the femoral mid-shaft was significantly 
lower in amenorrheic athletes compared to eumenorrheic athletes. Exercise may also however 
play more of a protective role in the maintenance of cortical bone than trabecular bone, as the 
weight bearing areas measured consist of a higher proportion of cortical bone mass than 
trabecular bone mass. Although there were no significant differences between the three 
groups in any of the regions of the proximal femur in our study, the BMD of the total hip, 
intertrochanteric region and the neck of the femur did tend to be lower in the sedentary group 
suggesting that exercise is important in the maintenance of BMD in these predominantly 
cortical, weight bearing areas. A study by Heinrich et al., (1990) found BMC of female body 
builders was greater than the BMC of inactive females at all sites measured on the axial and 
appendicular skeleton, however similar to our results, no significant differences were 
observed between endurance trained and inactive subjects. 
A study done in our laboratory by van Gend and Noakes (1987) concluded that short-term 
menstrual irregularity appears to be a direct result of the stresses of running training and 
racing. Their study showed that 41 % of the runners experienced short-term menstrual 
irregularity during periods of intensive training and competition. Many studies have shown a 
direct relationship between menstrual dysfunction and training load (Feicht et al., 1978; 
Schwartz et al., 1981; Sanborn et al., 1982; Drinkwater et al., 1984; Lindberg et al., 1984; 
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Drinkwater et al., 1986; Cook et al., 1987; Drinkwater et al., 1990). Our data showing the 
significant difference in maximum weekly mileage ever undertaken by the subjects in the 2 
running groups, appears to confirm their findings. However, it is not known whether the 
menstrual irregularity in this sample of women coincided with the increased training load, and 
other studies have not shown an association between training load and menstrual irregularity 
(Speroff and Redwine, 1980; Nelson et al., 1986; Myburgh et al., 1993). Therefore training 
load may be a contributing factor which becomes significant only if other risk factors are also 
present. 
Analysis of our data revealed that several anthropometric variables were either different 
between the 3 groups, or correlated with lumbar spine BMD. In particular, we will discuss 
issues related to i) body fat content, ii) body size and shape (weight relative to height) and iii) 
changes in the latter. 
i) Comparison between the 3 groups showed that the sedentary controls were heavier, more 
endomorphic, less ectomorphic, and had a higher BMI, estimated % body fat and fat mass 
than the other two groups. This may be largely a result of the differences in activity between 
the running groups and the sedentary group, but may also be due to a genetic predisposition to 
higher % body fat (Stunkard et al., 1986), which indirectly may have discouraged sports 
participation. The fact that the ectomorphic component (p<O.O 1 ), a measure of leanness and 
linearity, is more significantly different between the groups than BMI (p<0.05) suggests that 
the runners may have been originally more suited to running. However, there was no 
difference in mesomorphy, a measure on a scale of 1-7 of the degree of muscularity of the 
individual. Neither was fat free mass different between the three groups. Muscle mass has 
previously been related to bone mass (Aloia et al., 1995), and some cross-sectional studies 
have found that weight-training may be more closely associated with improved bone density 
than endurance training (Nilson and Westlin, 1971; Heinrich et al., 1990; Davee et al., 1990; 
Snow-Harter et al., 1992). However, our result is not surprising considering that endurance 
running increases muscle oxidative capacity rather than muscle size (Holloszy and Coyle, 
1984). 
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Estimated % body fat was also significantly lower in the OA group than the regularly 
menstruating runners. Since only 2 of the women in the OA group were currently 
experiencing menstrual irregularities, % body fat is not likely to be a direct mechanism 
responsible for menstrual irregularity, thus supporting data by Loucks et al. (1984) and 
Sanborn et al. (1987). Rather, those women who have a lower% body fat may be at a higher 
risk of menstrual irregularity as a result of other factors associated with low body fat such as 
higher training load, or inadequate energy intake, or both. 
ii) Since conventional densitometry only takes into account cross-sectional area but not bone 
width in the third dimension, the effect of the 3-dimensional bone size is not entirely corrected 
for, resulting in a potential source of error when measuring bones of different sizes. 
Therefore, Carter et al.(1992) described a new method of assessing bone density. Bone 
mineral apparent density (BMAD) is a more accurate method of comparing the density of 
bones of different sizes since it is height and weight independent (Carter et al., 1992). In our 
study, the significant difference in BMAD between the OA group and the SC group provides 
further evidence that the difference in bone status between the two groups is the result of 
menstrual disruptions of the OA group, rather than a difference in body size or shape (range 
for height in this study is 152 cm - 175 cm). BMI was significantly correlated with BMAD 
(r=0.41, p<0.05) and, together with a negative influence by DBMI, was a significant predictor 
of BMAD (r2=0.30, p<0.01). Therefore, the relationship of these same two variables with 
lumbar spine BMD was not likely a result of inadequate correction for bone size, but a true 
influence on these variables on osteopenia. Analysis of longitudinal data supplies some 
additional insights, particularly in individual subjects, (see section (b )). 
iii) Of all the physical characteristics, DBMI and BMI were the most significant predictors of 
lumbar spine BMD-(r2=0.36; p=0.01). Disordered or restricted eating, which may be the 
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cause of large fluctuations in body weight (measured by DBMI, which had a negative 
influence on lumbar spine BMD) and the disruption of energy balance, is associated with 
amenorrhea, and consequently related to bone mineral loss (Wilmore et al., 1991 ). BMI as a 
significant predictor of lumbar spine BMD suggests that not only weight, but also height is 
important in the determination of bone mass. The significant correlation between BMI and 
DBMI (r=0.60, p<0.001) suggests that currently larger women may have experienced larger 
fluctuations in body weight in the past. Also, the relationship between BMI, % body fat 
(r=0.73, p<0.001), and estimated energy expenditure (r=0.73, p<0.001), suggests that these 
women are also currently more physically active, possibly in an attempt to decrease body fat. 
Therefore, the influence of body size, as well as the change in body size, on lumbar spine 
BMD must not be ignored. 
(b) Longitudinal data 
A longitudinal study by Jonnavithula et al. (1993) on a sample of young women (13-29 years) 
noted significant increases in spine bone mineral density of young (mean age 20.4 ± 5.7 yr -
23.0 ± 5.8 yr) amenorrheic exercising women over a 2 year period (14.3%), regardless of lack 
of menstrual periods. In our sample of much older women, lumbar spine BMD did not 
change significantly (-0.07%.yr-1) with an improvement in MHI. In contrast Lindberg et al., 
(1987) and Drinkwater et al., (1986) showed 6.6% and 6.2% increases per annum 
respectively. However, their subjects were younger than ours and had all been amenorrheic at 
baseline whereas our subjects had a prior history of oligo/amenorrhea and only one of our 
subjects was amenorrheic at baseline. Our study was designed to determine the potential long 
term accretion of bone mass in women with a history of menstrual irregularity. Our data 
suggests that peak bone mass may already have been reached at the time of the baseline 
measurements and that BMD may not increase substantially after± 35 years of age, regardless 
of menstrual history. Although this conclusion is correct for all our subjects with a history of 
regular menses and 90% of our subjects with a history of menstrual irregularities, one subject 
did not follow this frend and will be presented as a special case report (see Chapter 4). Bone 
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mass also did not decrease in our subjects. Our data therefore concurs with Madsen (1977) 
who showed that BMC did not decrease until 50-60 years of age, as well as Recker et al. 
(1992b) who concluded that bone gain occurs in healthy young women during the third 
decade of life. Another study of healthy premenopausal women ( aged 19-51 years) showed 
2% increases per annum in peak bone mass up to age 34 years followed immediately by an 
average decline in lumbar spine BMD of 2.2% per annum (Krolner and Nielsen, 1982). Our 
data do not support this magnitude of decrease at this age. Buchanan et al., (1988) concluded 
that 0.7% of vertebral trabecular bone is lost per annum in the fourth and fifth decade oflife. 
Data from some of our subjects concur, but there was no significant change in the mean. 
Another study by Prior et al. (1990) in apparently regularly menstruating premenopausal 
women (n=66; 21-42 years of age) reported an average decrease of 2% per annum in spinal 
bone density. But a more substantial decrease(± 4%) was shown in two groups with either 
more than one menstrual cycle with a short luteal phase or anovulation. We did not measure 
either circulating estrogen or progesterone concentrations, but our insignificant change in 
lumbar spine BMD seems to indicate that the disturbances noted by Prior et al., ( 1990) were 
not present in the subjects in our study. The subject (37 years old) with the largest increase in 
MHI (7.1 to 9.6) since the previous test showed minimal improvement in lumbar spine BMD 
(+ 0.2 %.yr-1 ). However, during the age span of the subjects on this study the extent of 
change in lumbar spine BMD is variable, as well as the direction of that change, both of which 
appear to be independent of age and current menstrual status. For example, the subject who 
showed the largest increase in BMD (1.3 %.yr-1) had always had regular menses, was 42 
years of age and had only gained 1 kg of body mass since the first scan. 
Lindberg et al. (1987) associated their changes in BMD with increases in body mass. For the 
whole group we also found a significant positive correlation between the annualised change in 
lumbar spine BMD and the absolute change in body mass (r=0.36, p=0.05). The only subject 
who showed a negative annual change larger than 1 % in lumbar spine BMD was 32 years old 
and had always had·regular menses. She only lost 1.5 kg since her first scan three years 
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previously, but no other factors relating to diet or training had changed significantly. Several 
studies have stressed the importance of genetic factors in the determination of peak bone mass 
(Pocock et al., 1987; Matkovic et al., 1990; Seeman et al., 1990; Armamento-Villareal et al., 
1992). Unfortunately family history of osteoporosis was not recorded in this study, and as all 
environmental factors have been well controlled for it can be hypothesised that there may be a 
genetic influence on rate of bone loss, classifying this subject as an "early loser". Three 
subjects showed a positive annual change of 1 % or more in lumbar spine BMD. Although 
this does not represent a significant change and it may not be distinguishable from 
measurement error, it has been used as a level of rate of change from which to discuss 
particular individuals. One of the subjects (31 years old) had a history of menstrual 
irregularity but had regained and maintained regular menses for ten years prior to the second 
scan. Although there was no significant change in her body mass (-0.80 kg), she had 
dramatically reduced her training mileage which still included exercising 7 days a week. 
However, even with an increase in her lumbar spine BMD, this subject still had significant 
osteopenia. Another subject ( 43 years old) who exhibited a relatively large increase (> 1 %.yr-
1) in lumbar spine BMD was a sedentary control who had gained 15 kg since the initial study. 
The other subject ( 42 years old) who showed a> 1 %.yr-1 positive change in lumbar spine 
BMD did not show a significant change in body mass ( + 1 kg), training mileage, or menstrual 
status (she had always had regular menses). Therefore it is difficult to associate this increase 
with a change in lifestyle. These results are evidence that a wide variety of variables, some of 
which may not be related to lifestyle, influence lumbar spine BMD and even large gains in 
body mass may not always result in a large accretion of bone mass. 
Two subjects were experiencing menstrual irregularities at the time of the second scan. One 
of the subjects (36 years old) was experiencing oligomenorrhea and had an MHI of 9.23, a 
score -0.34 lower than at the first scan. In the time period between the two scans she had 
decreased her training mileage substantially and showed a decrease of 1 kg of body weight. 
The annualised change in her lumbar spine BMD was +0.14%.yr-1 which is not clearly not 
significant. This subject does not associate the oligomenorrhea, which she has experienced 
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for a total of 4 consecutive years, as well as between menarche and the age of 18 years, with a 
change in training, emotional distress, weight loss or food restriction. The other subject with 
menstrual irregularity at the time of the second scan was currently amenorrheic and had an 
MHI of 4.88, a slight increase since the first scan (+0.80). This 34 year-old subject had a 
history of 10 years of amenorrhea and 1 year of oligomenorrhea. Her training varies between 
40 km. wk-1 when she is not training for competition, and 13 0 km. wk-1 when she is training 
for competition. Lumbar spine (L 1-L4) BMD of this subject had decreased (-0.68%.yr-1) 
since her first scan five years previously and was 87% of age and sex matched normals. 
Lindberg et al. ( 1987) re-evaluated runners after a 15 month period and found a substantial 
increase in vertebral bone density in response to reduced exercise in previously amenorrheic 
runners, however these runners were not compared to age-matched eumenorrheic controls. 
Other studies (Lloyd et al., 1988, Drinkwater et al., 1986) that have shown similar large 
increases in vertebral bone mineral content over time have been done in a much younger 
sample of women. We hypothesise that younger women have a better ability to improve bone 
mass than women in their fourth decade. Also, the first 1-2 years after resumption of menses 
may represent a period of rapid increase in lumbar spine BMD, which subsequently plateau's. 
A possible limitation of this study is that more regular follow-ups, such as once a year, would 
have provided more information on the rate of change in bone mass. 
v CONCLUSIONS OF STUDY 2 
From study 2 we have provided further evidence that despite resumption of regular menses, 
previously irregularly menstruating runners still have reduced lumbar spine BMD compared 
to regularly menstruating runners. In addition they are also lower than sedentary controls. 
This suggests that lack of regular exercise is less detrimental to lumbar spine BMD than a 
history of menstrual irregularity. A history of menstrual irregularity has a significant negative 
effect on trabecular.bone mass, however cortical bone mass remains unchanged. 
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Although adolescence is an important period in the attainment of high bone mass, it is the 
period immediately following adolescence, the third decade, that may be more significant in 
ensuring the maintenance of a high peak bone mass. This study suggests that BMD may not 
increase substantially during the fourth and fifth decades, regardless of current or previous 
menstrual status. We propose that interventions to improve bone mass in athletes with a 
history of menstrual irregularity should be a priority in the third decade. 
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CHAPTER4 
CASE REPORT 
Introduction 
Many studies have confirmed the significant direct relationship between current 
menstrual status and bone mineral density (Drinkwater et al., 1984; Lindberg et al., 1984; 
Marcus et al., 1985; Nelson et al., 1986; Cook et al., 1987; Drinkwater et al., 1990; 
Warren et al., 1991; Jonnavithula et al., 1993; My burgh et al., 1993; Rutherford, 1993; 
Micklesfield et al., 1995), and more literature is emerging regarding the influence of 
overall history of menstrual dysfunction (Drinkwater et al., 1990; Grimston et al., 1990; 
Myburgh et al., 1993; Micklesfield et al., 1995) on bone status. These two variables, 
along with others such as body mass, functional loading, energy intake and calcium 
balance may determine peak bone mass. Complex interrelationships between these 
variables may also exist. It has been suggested that physical activity, especially if it is 
weight-bearing, may act to increase BMD (Nilson and Westlin 1971; Aloia, 1981; 
Marcus et al., 1985). However, large training volumes and inadequate energy intake are 
also associated with oligo/amenorrhea (Rippon et al., 1988), low endogenous estrogen 
concentrations (Drinkwater et al., 1986), low calcium intake (Nelson et al., 1986) and 
consequently, osteopenia. Few longitudinal studies exist which report significant 
changes in bone mass with resumption of menses (Drinkwater et al., 1986; Lindberg et 
al., 1987; Jonnavithula et al., 1993). Although dramatic improvements in lumbar spine 
BMD of up to 6.6% in the first year have been reported (Lindberg et al., 1987), mean 
lumbar spine bone mass was still significantly lower than in athletic controls who had 
always been regular. It is still unknown whether lumbar spine BMD can, with time, 
improve enough to equal age-matched normals. In this report, we present a 3 year 
follow-up of a distance runner who was amenorrheic at baseline and menstruating 
regularly 3 years later. 
11 Methods 
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The subject was originally recruited as part of a cross-sectional study of BMD in mature 
distance runners (Micklesfield et al., 1995) (T1). Three years later she agreed to a 
follow-up study (T2). She was also part of a larger study at T2, but was a significant 
outlier compared with all the other subjects (n=29) and is therefore reported separately. 
The subject had an osteodensitometry scan of the lumbar spine and the left proximal 
femur (Hologic QDR-1000, version 4.20). 
A detailed questionnaire was completed in order to obtain more detailed information 
about her current menstrual status and previous menstrual history. This information was 
used to calculate the Menstrual History Index (modified from Grimston et al., 1990), as 
described in Micklesfield et al., (1995). Information about previous dairy product intake 
was also obtained from the questionnaire and was reported as the estimated number of 
portions consumed per week during junior school, high school, on leaving school and 
over the past year. For details see Micklesfield et al., (1995). A 3 day dietary record was 
obtained in order to determine total energy intake (MJ) per day, as well as daily intake of 
calcium (mg), phosphorus (mg), protein (g), fat (g), carbohydrate (g), and fibre (g). The 
record was analysed by a computerised dietary analysis programme (Foodfinder, Medical 
Research Council. Parow, South Africa). Daily energy expenditure (MJ.d-1) was 
estimated from a seven day activity diary (modified Blair et al., 1985). 
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Body composition was measured and calculated according to the method of Durnin and 
Wormesley ( 197 4 ). Somatotype was assessed using the Heath-Carter method ( 1967). 
A venous blood sample were drawn in the morning in order to determine osteocalcin 
concentration by means of a specific radioimmunoassay performed on serum (OSTK-PR 
Kit, CIS bio international, ORIS Group, France). 
A twenty-four hour urine sample was obtained from SI2 in order to determine the 
concentration of free deoxypyridinoline cross-links (DPD), corrected for urinary 
concentration by creatinine (Metra Biosystems, Inc). 
111 Report 
Subject no 12 (SI2) was a 29 year old ultramarathon runner at the time of the test 1 and 
was tested again 3 years later (test 2) at age 32 years. She started training for marathons 
at the age of 28 years. She participated in a 56 km ultramarathon three times in the 
period between the two tests, her best time was 4 hours and 42 minutes. Her height at 
test 1 and 2 was 170 cm, however her body mass increased from 58 kg to 60 kg from test 
1 to test 2. 
Her exercise schedule consisted of running five times a week for approximately an hour 
at a time. When training for marathon competition her weekly running distance was 75-
95 km. She also participated in aerobic dance exercise four times a week and circuit 
weight training three times a week. Other regular, though not routine, aerobic activities 
included cycling and walking. She did not change her training significantly between test 
1 and 2, and her competition times had stayed more or less similar. 
At the time of her first bone density scan S 12 was amenorrheic and had experienced on 
average 2 periods.yr-I for the three years preceding her first scan. Before that she had 
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been either oligomenorrheic or amenorrheic since the age of 18 years. The reduction in 
the frequency of menses coincided with a rapid loss of weight, viz. 38 kg in 21 weeks, 
achieved through dieting. At the time of her first scan she weighed 58 kg (her lowest 
weight as an adult). At the time of her second scan she weighed 60 kg. Her highest 
weight as an adult was 96 kg, a year and a half prior to test 1. At the time of the second 
scan she had a BMI of 21 kg.m-2, however due to the large fluctuation in weight her 
DBMI was 15.4 kg.m-2. This value placed her more than 2 standard deviations above the 
average of the rest of the subject sample (4.21 kg.m-2 ± 2.2; n=29). At the time of her 
first scan, her% body fat was 31.8%, however it had dropped to 25.9% at the time of her 
second scan. Lean body mass had increased from 68.2% to 74.1 % in this time, which 
may be as a result of the inclusion of weight training in her exercise routine. 
S 12 started menstruating at the age of 14 years. At the time of the first scan S 12 had an 
MHI of 6.50 which increased to 9 .25 at the time of the second scan three years later due 
to the regulation of her menstrual cycle. She had experienced 6 years of amenorrhea and 
3 years of oligomenorrhea in total prior to test 2. 
S 12 has two children aged 12 years and 8 years whom she breastfed for a total of 5 years. 
She had taken the oral contraceptive pill for a total of two years after giving birth to her 
second child. At the time of the first and second scan she was not taking any oral 
contraceptive. 
Her estimated daily calcium intake at test 1 was 708 mg.ct-I and at test 2, 548 mg.ct-I. It 
was derived mainly from the milk she had in her tea and coffee and some cheese in a 
salad. As a child she was deprived of dairy products and her dairy intake consisted of 
condensed milk and canned milk diluted with water. Estimated portions of dairy.wk-I 
during her junior school years was estimated to be 10, during high school 21 portions.wk-
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1, and since leaving school between 2 and 4 portions. wk-1. Total energy intake at test 1 
was 4492 kJ, and test 2 was 3940 kJ, which was 48% and 43% of the RDA for adult 
women (The Recommended Daily Allowance, 10th edition. © National Academy of 
Sciences, 1989). 
S 12 took no supplements but was treated for insomnia with a flunitrazepam (rohypnol, 
Roche). 
Lumbar spine BMD at the time of the first bone density scan was 0.796 g.cm-2 and 
increased to 0.893 g.cm-2 at the time of the second scan, an annual increase of 4.0%, but 
a total of 12% in 3 years. The average BMD of the lumbar spine for the second scan was 
within the normal range when compared to age matched and young normals (reference 
curve for American females, Hologic QDR-1000, October 1984), but still only 86% of 
the mean. However the BMD of L 1 was just below the fracture threshold of 0. 827 g.cm-
2 and L4 showed significant osteopenia which is worse than expected for her age and 
gender. 
The BMD of the left hip was normal at the time of the first and second scan. Since the 
first scan, all areas in the left hip had increased in BMD. The annualised changes were: 
neck of the femur: + 1. 9% per annum, greater trochanter: + 3 .2% per annum, 
intertrochanteric space: +2.3% per annum, the total proximal femur: +2.6% per annum, 
Wards triangle: +0.8% per annum. All areas except Ward's triangle were above the T-
score. Ward's triangle was equal to the T-score. 
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Table 4.1: Bone mineral density of the lumbar spine and the proximal femur at test 1 (Tt) and test 2 
(T2)• 
BMD(g.cm-2) % age matched T-score 
Site T1 T2 T1 T2 T1 T2 
L1 0.736 0.825 80% 89% -1.72 -0.91 
L2 0.791 0.935 77% 91% -2.16 -0.84 
L3 0.878 0.961 81% 89% -1.87 -1.12 
L4 0.769 0.847 69% 76% -3.16 -2.45 
L1-L4 0.796 0.893 76% 86% -2.28 -1.40 
Femoral neck 0.978 1.034 110% 118% +0.83 +l.40 
Trochanter 0.751 0.826 104% 115% +0.32 +l.15 
Intertrochanter 1.202 1.285 105% 112% +0.39 +0.99 
Total hip 1.029 1.110 106% 114% +0.53 +1.13 
Wards triangle 0.771 0.789 102% 107% -0.23 -0.06 
Urinary calcium was measured in the first test at 0.210 mmol.2hr-1, however for test 2 
DPD/Creatinine was measured and a value of 5 .3 nM Dpd.mM Creat-1 was obtained. 
Similarly different blood tests were performed for the different tests. Estradiol 
concentration for the first test was 80 pMol/1, while osteocalcin had a value of 7.2 ng.ml-
1 for the second test. Osteocalcin values generally vary between 2 and 12 ng.ml-1 
(Gundberg, 1990), and reference values for Pyrilinks-D range from 2.0-6.0 nM Dpd.mM 
Crear 1. 
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iv Discussion 
The annualised changes in BMD of Sl2 were significant and provide further evidence of 
the positive effect of the resumption ofregular menses on BMD. However, lumbar spine 
BMD was still significantly lower than that of age matched normals (86%). 
In S 12 low lumbar spine BMD had a mulitifactorial origin including lifelong lower than 
recommended calcium intake, extreme weight loss (though no clinical treatment for an 
eating disorder) and a history of amenorrhea and oligomenorrhea. The menstrual 
irregularity was associated with a long period of breastfeeding and both the extreme 
weight loss and training for an ultramarathon, both of which occurred late in life. 
Following test 1 the subject was informed of the status of her bone health and advised of 
the lifestyle factors which contributed to this. S 12 desisted from further weight loss, 
decreased running training at times, however not when training for an ultramarathon (± 6 
months.yr-I), but did not consciously alter calcium intake. Menses regularised 
spontaneously within one year after test 1 and coincided with the removal of an ovarian 
cyst. Regular menses probably had the largest influence on the gain in BMD in the 
subsequent three years. However regular weight training may also have contributed. 
Heinrich et al., (1990) and others (Nilson and Westlin, 1971; Davee et al., 1990, Snow-
Harter et al., 1992) have suggested that weight training may be a better stimulus for 
improving bone status than running and swimming. 
Sl2 was 32 years of age at test 2. Although several studies would predict that by this age 
peak bone mass would already be achieved (Lloyd et al., 1988; Bonjour et al., 1991; 
Armamento-Villareal et al., 1992), other studies infer that S12 could still gain bone mass 
up to the age of 34 years (Krolner and Nielsen, 1982), and perhaps right up to 50-60 years 
of age (Madsen, 1977). If lumbar spine BMD continued to increase at the present rate ie. 
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4%.yr-1, S 12 would reach the mean level of "young-normals" in 4 years. However, our 
other longitudinal data indicates <1 %.yr-1 increase in previously irregularly menstruating 
women with a mean age of 35.9 ± 4.4 yr. These subjects had already menstruated 
regularly for an average of 11.7 ± 7.9 years, and were on average older than S12. It is 
unknown whether the better rate of improvement of BMD in S12 is related to age, 
severity of previous irregularity, or weight training and whether it will continue at the 
same rate or slow down. 
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APPENDICES 
APPENDIX 1 
BONE DENSITY QUESTIONNAIRE 
Name: 
--------
Address:--------- (h) 
Tel No: 
Date today: ____ _ 
PHYSICAL DETAILS 
Age: yrs (Birth date: ----~ 
Height: m 
Mass: Current weight: __ kg 
Lowest adult weight: __ kg (When? _______ _, 
Highest adult weight: __ kg ( excluding pregnancy) 
(When? ______ ~ 
TRAINING 
1. How many years have you been training for marathons? 
____ years 
2. What is your minimum and maximum weekly mileage when training for marathon 
competition? 
Minimum: km/wk Maximum: km/wk 
3. What is your minimum and maximum weekly mileage when not training for marathon 
competition? 
Minimum: km/wk Maximum: km/wk 
4. Have you altered your training in the past five years? 
If so,how? __________________________ _ 
5. Please record your personal best times for the respective distances for each year 1991-
1994: 
10km 1/2 marathon Two Oceans Comrades 
1991 
1992 
1993 
1994 
6. Do you participate in any other forms of exercise, besides running? YES/NO 
How many times per week do you participate in exercise, including running, at 
present? times/wk. 
7. Please complete the table below: 
EXERCISE FREQUENCY/ DURATION/ DISTANCE/ MONTHS/YEARS 
WEEK WEEK WEEK PARTICIPATION 
Running 
Aerobics 
Swimming 
Cycling 
Gym training 
Other 
Other 
MEDICAL HISTORY 
1. Age at onset of menstruation? ___ years of age. 
2. Are you presently 
(i) pregnant YES/NO 
(ii) on the pill YES/NO 
(iii) menopausal YES/NO 
(iv) post menopausal YES/NO 
3. Have you had a hysterectomy or ovarectomy? YES/NO 
If yes, please state which one: _______ _ 
4. Have you ever experienced any menstrual irregularity? 
YES/NO 
5. If the answer to no.4 was yes, did you experience the irregularity: 
11 
5. If the answer to no.4 was yes, did you experience the irregularity: 
(i) between the onset of menstruation and the age of 18 YES/NO 
(ii) with an increase in exercise YES/NO 
(iii) anxiety related YES/NO 
(iv) with food restriction YES/NO 
(v) unknown reason YES/NO 
(vi) within the past 5 years YES/NO 
BONE DENSITY STUDY 
1. Would you be prepared to do another: 
(i) bone density test YES/NO 
(ii) dietary record YES/NO 
(iii) blood test YES/NO 
iii 
iv 
APPENDIX2 
DETAILED BONE DENSITY QUESTIONNAIRE (Initial consultation) 
Name: Date: 
-------
Tel No: (h) 
------
PHYSICAL DETAILS 
Age: yrs 
Height: m 
Current mass (hospital scale) ___ kg 
TRAINING 
Comments 
-----------
-----------
-----
MEDICAL AND MENSTRUAL HISTORY 
1 a. Age at menarche: 
--,-,--
1 b. Fill in the following table of questions: 
(i) Please mark in one of the columns the approximate number of periods you had per 
year at each age? 
(ii) Were you using oral contraceptives at any of these ages? 
(iii) Please indicate if you were pregnant. 
(iv) Other: please indicate if you underwent any of the following at any age: 
breastfeeding, fertility drugs (type), hormone injections (type), hysterectomy, 
hysterectomy and ovarectomy, miscarriage (no. of weeks). 
(iv) Any comments. 
(i) (ii) (iii) (iv) (v) 
Age: 0 1-3 4-6 7-9 10-13 0/C Pregnant Other Comments 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
Age 0 1-3 4-6 7-9 10-13 0/C Pregnant Other Comments 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
2a. How many children have you had? ___ _ 
b. How old are they?-,-__ ___,.. _ __,~-,---_,...,..-
c. How many months have you breastfed in total? ___ _ 
d. Did you take a calcium supplement at that time? YIN 
3a. Are you on any regular medication? YIN 
b. If "yes", please specify what medication and dose and for how long you have been 
taking this medication? 
4a. What was the date of your last period? _/_/_ 
b. How many days is your cycle ( eg. 28) ____ _ 
DIET 
1. Does your intake of dairy products vary a lot? YIN 
2. How many cups of milk do you think you drank per day? 
i) Over the past year? 
ii) In general since leaving school? ____ _ 
iii) At high school? 
iv) At junior school? 
3. How many portions of yoghurt did you drink per WEEK? 
(I portion = a 175ml container as sold in shop) 
i) Over the past year? 
ii) In general since leaving school? 
iii) At high school? -----
iv) At junior school? 
V 
4. How many portions of ice-cream did you eat per WEEK? 
( 1 portion = a scoop) 
i) Over the past year? 
ii) In general since leaving school? ____ _ 
iii) At high school? 
iv) At junior school? 
5. How many tubs of cottage cheese did you eat per WEEK? 
i) Over the past year? 
ii) In general since leaving school? ____ _ 
iii) At high school? 
iv) At junior school? 
6. How many times do you have a meal with cheese per WEEK? 
( eg. cheese sandwich, macaroni cheese etc.) 
i) Over the past year? 
ii) In general since leaving school? 
iii) At high school? 
iv) At junior school? 
Additional comments: 
vi 
